Advanced Search (OLGA)

Gene: TSC22D2 (TSC22 domain family member 2) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

TSC22D2

Name:

TSC22 domain family member 2

RGD ID:

1602336

HGNC Page

HGNC:29095

Description:

Involved in negative regulation of cell cycle.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

KIAA0669; TILZ4a; TILZ4b; TILZ4c; TSC22 domain family 2; TSC22 domain family protein 2; TSC22 domain family, member 2; TSC22-related-inducible leucine zipper protein 4

RGD Orthologs

Alliance Orthologs

More Info

more info ...

More Info

Species	Gene symbol and name	Data Source	Assertion derived from	less info ...
Orthologs ¹				less info ...
Mus musculus (house mouse):	Tsc22d2 (TSC22 domain family, member 2)	HGNC	Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):	Tsc22d2 (TSC22 domain family, member 2)	HGNC	Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Chinchilla lanigera (long-tailed chinchilla):	Tsc22d2 (TSC22 domain family member 2)	NCBI	Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):	TSC22D2 (TSC22 domain family member 2)	NCBI	Ortholog
Canis lupus familiaris (dog):	TSC22D2 (TSC22 domain family member 2)	HGNC	Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):	Tsc22d2 (TSC22 domain family member 2)	NCBI	Ortholog
Sus scrofa (pig):	TSC22D2 (TSC22 domain family member 2)	HGNC	Ensembl, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Chlorocebus sabaeus (green monkey):	TSC22D2 (TSC22 domain family member 2)	NCBI	Ortholog
Heterocephalus glaber (naked mole-rat):	Tsc22d2 (TSC22 domain family member 2)	NCBI	Ortholog
Alliance orthologs ³
Mus musculus (house mouse):	Tsc22d2 (TSC22 domain family, member 2)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Rattus norvegicus (Norway rat):	Tsc22d2 (TSC22 domain family, member 2)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Danio rerio (zebrafish):	tsc22d2 (TSC22 domain family 2)	Alliance	DIOPT (Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|SonicParanoid\|ZFIN)
Caenorhabditis elegans (roundworm):	T18D3.7	Alliance	DIOPT (Ensembl Compara\|OrthoFinder\|OrthoInspector)
Drosophila melanogaster (fruit fly):	bun	Alliance	DIOPT (Ensembl Compara\|InParanoid\|OrthoFinder\|OrthoInspector)
Xenopus tropicalis (tropical clawed frog):	tsc22d2	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Xenopus laevis (African clawed frog):	tsc22d2.S	Alliance	DIOPT (Xenbase)
Xenopus laevis (African clawed frog):	tsc22d2.L	Alliance	DIOPT (Xenbase)

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	150,408,298 - 150,466,422 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	150,408,298 - 150,466,422 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	150,126,085 - 150,184,209 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	151,609,478 - 151,660,321 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	3	148,539,824 - 148,590,663 (+)	NCBI		Celera
Cytogenetic Map	3	q25.1	NCBI
HuRef	3	147,500,522 - 147,551,293 (+)	NCBI		HuRef
CHM1_1	3	150,089,862 - 150,140,705 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	3	153,159,594 - 153,217,686 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
TSC22D2	Human	glycogen storage disease XV		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Glycogen storage disease XV	ClinVar	PMID:20357282 more ...
TSC22D2	Human	keratoconus		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Keratoconus	ClinVar

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
TSC22D2	Human	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		6480464	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TSC22D2 mRNA	CTD	PMID:22079256
TSC22D2	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Estradiol co-treated with TGFB1 protein] results in increased expression of TSC22D2 mRNA	CTD	PMID:30165855
TSC22D2	Human	17beta-estradiol	increases expression	EXP		6480464	Estradiol results in increased expression of TSC22D2 mRNA	CTD	PMID:31614463
TSC22D2	Human	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	2 more ...	CTD	PMID:23829299
TSC22D2	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	Tsc22d2 (Mus musculus)	6480464	Tetrachlorodibenzodioxin affects the expression of TSC22D2 mRNA	CTD	PMID:21570461
TSC22D2	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in increased expression of TSC22D2 mRNA	CTD	PMID:33387578
TSC22D2	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in decreased expression of TSC22D2 mRNA	CTD	PMID:32109520
TSC22D2	Human	2,6-dimethoxyphenol	multiple interactions	EXP		6480464	[Sodium Chloride co-treated with pyrogallol 1 more ...	CTD	PMID:38598786
TSC22D2	Human	2-methylcholine	affects expression	EXP		6480464	beta-methylcholine affects the expression of TSC22D2 mRNA	CTD	PMID:21179406
TSC22D2	Human	3,4-methylenedioxymethamphetamine	decreases expression	ISO	Tsc22d2 (Mus musculus)	6480464	N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of TSC22D2 mRNA	CTD	PMID:26251327
TSC22D2	Human	4-hydroxyphenyl retinamide	decreases expression	ISO	Tsc22d2 (Mus musculus)	6480464	Fenretinide results in decreased expression of TSC22D2 mRNA	CTD	PMID:28973697
TSC22D2	Human	6-propyl-2-thiouracil	decreases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Propylthiouracil results in decreased expression of TSC22D2 mRNA	CTD	PMID:30047161
TSC22D2	Human	amitrole	decreases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Amitrole results in decreased expression of TSC22D2 mRNA	CTD	PMID:30047161 and PMID:38685447
TSC22D2	Human	antirheumatic drug	increases expression	EXP		6480464	Antirheumatic Agents results in increased expression of TSC22D2 mRNA	CTD	PMID:24449571
TSC22D2	Human	arsenous acid	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of TSC22D2 mRNA	CTD	PMID:20458559
TSC22D2	Human	benzene	decreases expression	ISO	Tsc22d2 (Mus musculus)	6480464	Benzene results in decreased expression of TSC22D2 mRNA	CTD	PMID:37084897
TSC22D2	Human	benzo[a]pyrene	increases expression	ISO	Tsc22d2 (Mus musculus)	6480464	Benzo(a)pyrene results in increased expression of TSC22D2 mRNA	CTD	PMID:21569818 and PMID:22228805
TSC22D2	Human	benzo[a]pyrene	increases methylation	EXP		6480464	Benzo(a)pyrene results in increased methylation of TSC22D2 promoter	CTD	PMID:27901495
TSC22D2	Human	bisphenol A	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	bisphenol A results in increased expression of TSC22D2 mRNA	CTD	PMID:25181051 more ...
TSC22D2	Human	bisphenol A	increases expression	EXP		6480464	bisphenol A results in increased expression of TSC22D2 protein	CTD	PMID:32981897
TSC22D2	Human	cadmium atom	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TSC22D2 mRNA	CTD	PMID:35301059
TSC22D2	Human	cadmium dichloride	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TSC22D2 mRNA	CTD	PMID:35301059
TSC22D2	Human	cisplatin	multiple interactions	EXP		6480464	[Cisplatin co-treated with jinfukang] results in decreased expression of TSC22D2 mRNA	CTD	PMID:27392435
TSC22D2	Human	cisplatin	decreases expression	EXP		6480464	Cisplatin results in decreased expression of TSC22D2 mRNA	CTD	PMID:27392435
TSC22D2	Human	copper(II) sulfate	increases expression	EXP		6480464	Copper Sulfate results in increased expression of TSC22D2 mRNA	CTD	PMID:19549813
TSC22D2	Human	coumarin	increases phosphorylation	EXP		6480464	coumarin results in increased phosphorylation of TSC22D2 protein	CTD	PMID:35688186
TSC22D2	Human	crocidolite asbestos	increases expression	EXP		6480464	Asbestos and Crocidolite results in increased expression of TSC22D2 mRNA	CTD	PMID:18687144
TSC22D2	Human	cyclosporin A	increases expression	EXP		6480464	Cyclosporine results in increased expression of TSC22D2 mRNA	CTD	PMID:20106945 and PMID:25562108
TSC22D2	Human	diarsenic trioxide	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of TSC22D2 mRNA	CTD	PMID:20458559
TSC22D2	Human	diazinon	increases methylation	EXP		6480464	Diazinon results in increased methylation of TSC22D2 gene	CTD	PMID:22964155
TSC22D2	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of TSC22D2 mRNA	CTD	PMID:37042841
TSC22D2	Human	diclofenac	increases expression	ISO	Tsc22d2 (Mus musculus)	6480464	Diclofenac results in increased expression of TSC22D2 mRNA	CTD	PMID:26934552
TSC22D2	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ...	CTD	PMID:27188386
TSC22D2	Human	doxorubicin	decreases expression	EXP		6480464	Doxorubicin results in decreased expression of TSC22D2 mRNA	CTD	PMID:29803840
TSC22D2	Human	ethanol	affects splicing	ISO	Tsc22d2 (Mus musculus)	6480464	Ethanol affects the splicing of TSC22D2 mRNA	CTD	PMID:30319688
TSC22D2	Human	ethyl methanesulfonate	decreases expression	EXP		6480464	Ethyl Methanesulfonate results in decreased expression of TSC22D2 mRNA	CTD	PMID:23649840
TSC22D2	Human	flutamide	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Flutamide results in increased expression of TSC22D2 mRNA	CTD	PMID:24136188
TSC22D2	Human	folic acid	decreases expression	ISO	Tsc22d2 (Mus musculus)	6480464	Folic Acid results in decreased expression of TSC22D2 mRNA	CTD	PMID:25629700
TSC22D2	Human	formaldehyde	decreases expression	EXP		6480464	Formaldehyde results in decreased expression of TSC22D2 mRNA	CTD	PMID:20655997
TSC22D2	Human	FR900359	increases phosphorylation	EXP		6480464	FR900359 results in increased phosphorylation of TSC22D2 protein	CTD	PMID:37730182
TSC22D2	Human	fulvestrant	increases methylation	EXP		6480464	Fulvestrant results in increased methylation of TSC22D2 gene	CTD	PMID:31601247
TSC22D2	Human	furfural	multiple interactions	EXP		6480464	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TSC22D2 protein and [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of TSC22D2 protein	CTD	PMID:38598786
TSC22D2	Human	gentamycin	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Gentamicins results in increased expression of TSC22D2 mRNA	CTD	PMID:22061828 and PMID:33387578
TSC22D2	Human	glycidol	decreases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	glycidol results in decreased expression of TSC22D2 mRNA	CTD	PMID:24915197
TSC22D2	Human	hydrogen peroxide	affects expression	EXP		6480464	Hydrogen Peroxide affects the expression of TSC22D2 mRNA	CTD	PMID:23410634
TSC22D2	Human	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		6480464	Arbutin results in decreased expression of TSC22D2 mRNA	CTD	PMID:17103032
TSC22D2	Human	ivermectin	decreases expression	EXP		6480464	Ivermectin results in decreased expression of TSC22D2 protein	CTD	PMID:32959892
TSC22D2	Human	leflunomide	increases expression	EXP		6480464	leflunomide results in increased expression of TSC22D2 mRNA	CTD	PMID:28988120
TSC22D2	Human	Licochalcone B	increases expression	EXP		6480464	licochalcone B results in increased expression of TSC22D2 mRNA	CTD	PMID:33647349
TSC22D2	Human	menadione	affects expression	EXP		6480464	Vitamin K 3 affects the expression of TSC22D2 mRNA	CTD	PMID:23410634
TSC22D2	Human	methimazole	decreases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Methimazole results in decreased expression of TSC22D2 mRNA	CTD	PMID:30047161 and PMID:38685447
TSC22D2	Human	methylisothiazolinone	increases expression	EXP		6480464	2-methyl-4-isothiazolin-3-one results in increased expression of TSC22D2 mRNA	CTD	PMID:31629900
TSC22D2	Human	ozone	increases expression	ISO	Tsc22d2 (Mus musculus)	6480464	Ozone results in increased expression of TSC22D2 mRNA	CTD	PMID:21543283
TSC22D2	Human	ozone	multiple interactions	EXP		6480464	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TSC22D2 mRNA	CTD	PMID:35430440
TSC22D2	Human	paracetamol	multiple interactions	ISO	Tsc22d2 (Mus musculus)	6480464	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TSC22D2 mRNA]	CTD	PMID:18700144
TSC22D2	Human	paracetamol	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Acetaminophen results in increased expression of TSC22D2 mRNA	CTD	PMID:33387578
TSC22D2	Human	paracetamol	increases expression	EXP		6480464	Acetaminophen results in increased expression of TSC22D2 mRNA	CTD	PMID:21420995 and PMID:29067470
TSC22D2	Human	paraquat	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Paraquat results in increased expression of TSC22D2 mRNA	CTD	PMID:32680482
TSC22D2	Human	PCB138	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	2 more ...	CTD	PMID:23829299
TSC22D2	Human	phenobarbital	affects expression	ISO	Tsc22d2 (Mus musculus)	6480464	Phenobarbital affects the expression of TSC22D2 mRNA	CTD	PMID:23091169
TSC22D2	Human	phenylmercury acetate	increases expression	EXP		6480464	Phenylmercuric Acetate results in increased expression of TSC22D2 mRNA	CTD	PMID:26272509
TSC22D2	Human	phenylmercury acetate	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSC22D2 mRNA	CTD	PMID:27188386
TSC22D2	Human	potassium chromate	increases expression	EXP		6480464	potassium chromate(VI) results in increased expression of TSC22D2 mRNA	CTD	PMID:22079256
TSC22D2	Human	potassium chromate	multiple interactions	EXP		6480464	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TSC22D2 mRNA	CTD	PMID:22079256
TSC22D2	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ...	CTD	PMID:27188386
TSC22D2	Human	silicon dioxide	increases expression	EXP		6480464	Silicon Dioxide results in increased expression of TSC22D2 mRNA	CTD	PMID:25351596
TSC22D2	Human	silver atom	decreases expression	ISO	Tsc22d2 (Mus musculus)	6480464	Silver results in decreased expression of TSC22D2 mRNA	CTD	PMID:27131904
TSC22D2	Human	silver atom	increases expression	EXP		6480464	Silver results in increased expression of TSC22D2 mRNA	CTD	PMID:26014281
TSC22D2	Human	silver(0)	decreases expression	ISO	Tsc22d2 (Mus musculus)	6480464	Silver results in decreased expression of TSC22D2 mRNA	CTD	PMID:27131904
TSC22D2	Human	silver(0)	increases expression	EXP		6480464	Silver results in increased expression of TSC22D2 mRNA	CTD	PMID:26014281
TSC22D2	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of TSC22D2 mRNA	CTD	PMID:38568856
TSC22D2	Human	sodium arsenite	increases expression	ISO	Tsc22d2 (Mus musculus)	6480464	sodium arsenite results in increased expression of TSC22D2 mRNA	CTD	PMID:36209798
TSC22D2	Human	sodium chloride	multiple interactions	EXP		6480464	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TSC22D2 protein more ...	CTD	PMID:38598786
TSC22D2	Human	sulfadimethoxine	decreases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Sulfadimethoxine results in decreased expression of TSC22D2 mRNA	CTD	PMID:30047161
TSC22D2	Human	sunitinib	decreases expression	EXP		6480464	Sunitinib results in decreased expression of TSC22D2 mRNA	CTD	PMID:31533062
TSC22D2	Human	tert-butyl hydroperoxide	affects expression	EXP		6480464	tert-Butylhydroperoxide affects the expression of TSC22D2 mRNA	CTD	PMID:23410634
TSC22D2	Human	tetrachloromethane	increases expression	ISO	Tsc22d2 (Mus musculus)	6480464	Carbon Tetrachloride results in increased expression of TSC22D2 mRNA	CTD	PMID:27339419 and PMID:31919559
TSC22D2	Human	tetrachloromethane	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Carbon Tetrachloride results in increased expression of TSC22D2 mRNA	CTD	PMID:31150632
TSC22D2	Human	thioacetamide	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Thioacetamide results in increased expression of TSC22D2 mRNA	CTD	PMID:23411599 and PMID:34492290
TSC22D2	Human	thiram	increases expression	EXP		6480464	Thiram results in increased expression of TSC22D2 mRNA	CTD	PMID:38568856
TSC22D2	Human	titanium dioxide	decreases methylation	ISO	Tsc22d2 (Mus musculus)	6480464	titanium dioxide results in decreased methylation of TSC22D2 gene	CTD	PMID:35295148
TSC22D2	Human	trichostatin A	increases expression	EXP		6480464	trichostatin A results in increased expression of TSC22D2 mRNA	CTD	PMID:24935251 and PMID:26272509
TSC22D2	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSC22D2 mRNA	CTD	PMID:27188386
TSC22D2	Human	urethane	increases expression	EXP		6480464	Urethane results in increased expression of TSC22D2 mRNA	CTD	PMID:28818685
TSC22D2	Human	valproic acid	affects expression	ISO	Tsc22d2 (Mus musculus)	6480464	Valproic Acid affects the expression of TSC22D2 mRNA	CTD	PMID:17963808
TSC22D2	Human	valproic acid	affects splicing	ISO	Tsc22d2 (Rattus norvegicus)	6480464	Valproic Acid affects the splicing of TSC22D2 mRNA	CTD	PMID:29427782
TSC22D2	Human	valproic acid	increases expression	EXP		6480464	Valproic Acid results in increased expression of TSC22D2 mRNA	CTD	PMID:28001369
TSC22D2	Human	valproic acid	affects expression	EXP		6480464	Valproic Acid affects the expression of TSC22D2 mRNA	CTD	PMID:25979313
TSC22D2	Human	valproic acid	increases methylation	EXP		6480464	Valproic Acid results in increased methylation of TSC22D2 gene	CTD	PMID:29154799
TSC22D2	Human	vinclozolin	increases expression	ISO	Tsc22d2 (Rattus norvegicus)	6480464	vinclozolin results in increased expression of TSC22D2 mRNA	CTD	PMID:23034163
TSC22D2	Human	vitamin E	decreases expression	EXP		6480464	Vitamin E results in decreased expression of TSC22D2 mRNA	CTD	PMID:19244175
TSC22D2	Human	zinc atom	multiple interactions	EXP		6480464	[PCI 5002 co-treated with Zinc] results in increased expression of TSC22D2 mRNA	CTD	PMID:18593933
TSC22D2	Human	zinc(0)	multiple interactions	EXP		6480464	[PCI 5002 co-treated with Zinc] results in increased expression of TSC22D2 mRNA	CTD	PMID:18593933

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
TSC22D2	Human	negative regulation of cell cycle	involved_in	IMP		150520179	PMID:27573352	UniProt	PMID:27573352
TSC22D2	Human	regulation of transcription by RNA polymerase II	involved_in	IEA	InterPro:IPR000580	150520179		InterPro	GO_REF:0000002
TSC22D2	Human	response to osmotic stress	acts_upstream_of_or_within	IEA	UniProtKB:E9Q7M2 and ensembl:ENSMUSP00000096688	150520179		Ensembl	GO_REF:0000107

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
TSC22D2	Human	protein binding	enables	IPI	UniProtKB:P14618	150520179	PMID:27573352	UniProt	PMID:27573352
TSC22D2	Human	protein binding	enables	IPI	UniProtKB:Q9BQA1	150520179	PMID:27337956	UniProt	PMID:27337956
TSC22D2	Human	protein binding	enables	IPI	UniProtKB:Q9UHY1	150520179	PMID:22510880	UniProt	PMID:22510880

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
TSC22D2	Human	Keratoconus		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Keratoconus	ClinVar

#	Reference Title	Reference Citation
1.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:8889548	PMID:8889549	PMID:9734811	PMID:12477932	PMID:12665801	PMID:14702039	PMID:15489334	PMID:18029348	PMID:19274049	PMID:20149264	PMID:22479202	PMID:22510880
PMID:23382044	PMID:26186194	PMID:27337956	PMID:27573352	PMID:27609421	PMID:28514442	PMID:29507755	PMID:29987050	PMID:31125406	PMID:31253590	PMID:32160551	PMID:32694731
PMID:32707033	PMID:33961781	PMID:34079125	PMID:34349018	PMID:34672947	PMID:35044719	PMID:35271311

TSC22D2
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	150,408,298 - 150,466,422 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	150,408,298 - 150,466,422 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	150,126,085 - 150,184,209 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	151,609,478 - 151,660,321 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	3	148,539,824 - 148,590,663 (+)	NCBI		Celera
Cytogenetic Map	3	q25.1	NCBI
HuRef	3	147,500,522 - 147,551,293 (+)	NCBI		HuRef
CHM1_1	3	150,089,862 - 150,140,705 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	3	153,159,594 - 153,217,686 (+)	NCBI		T2T-CHM13v2.0

Tsc22d2
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	3	58,322,123 - 58,374,208 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	3	58,322,136 - 58,374,204 (+)	Ensembl		GRCm39 Ensembl
GRCm38	3	58,414,702 - 58,466,787 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	3	58,414,715 - 58,466,783 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	3	58,219,611 - 58,270,709 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	3	58,503,618 - 58,554,716 (+)	NCBI		MGSCv36	mm8
Celera	3	58,108,756 - 58,159,832 (+)	NCBI		Celera
Cytogenetic Map	3	D	NCBI
cM Map	3	28.51	NCBI

Tsc22d2
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	2	144,796,760 - 144,847,930 (+)	NCBI		GRCr8
mRatBN7.2	2	142,646,778 - 142,697,977 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	2	142,644,744 - 142,693,606 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	2	149,286,576 - 149,332,836 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	2	147,392,597 - 147,438,876 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	2	142,024,997 - 142,071,278 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	2	148,607,148 - 148,659,632 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	2	148,607,748 - 148,655,261 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	2	168,024,657 - 168,077,159 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	2	147,754,030 - 147,799,940 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	2	137,076,548 - 137,123,076 (+)	NCBI		Celera
Cytogenetic Map	2	q26	NCBI

Tsc22d2
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0	NW_004955448	1,639,463 - 1,678,279 (+)	NCBI	ChiLan1.0	ChiLan1.0

TSC22D2
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	2	148,292,168 - 148,349,039 (+)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	3	148,298,654 - 148,360,073 (+)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	3	147,426,058 - 147,484,285 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	3	155,000,654 - 155,051,795 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	3	155,001,006 - 155,050,323 (+)	Ensembl	panpan1.1		panPan2

TSC22D2
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	23	45,086,583 - 45,136,094 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	23	45,087,628 - 45,133,903 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	23	44,952,592 - 45,000,409 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	23	45,715,000 - 45,762,894 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	23	45,715,169 - 45,764,337 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	23	45,304,490 - 45,352,300 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	23	45,356,892 - 45,404,722 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	23	45,607,951 - 45,655,781 (+)	NCBI		UU_Cfam_GSD_1.0

Tsc22d2
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024405602	90,871,162 - 90,922,455 (-)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936758	845,528 - 892,059 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936758	845,359 - 898,937 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

TSC22D2
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	13	90,641,175 - 90,691,568 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	13	90,640,490 - 90,697,671 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	13	98,710,840 - 98,761,868 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

TSC22D2
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	15	40,232,247 - 40,284,936 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	15	40,233,732 - 40,283,899 (-)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666041	13,053,315 - 13,105,931 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Tsc22d2
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624730	27,821,862 - 27,863,344 (+)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624730	27,821,638 - 27,869,805 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in TSC22D2
85 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 3q24-26.32(chr3:147442566-178522531)x3	copy number gain	See cases [RCV000051724]	Chr3:147442566..178522531 [GRCh38] Chr3:147160353..178240319 [GRCh37] Chr3:148643043..179723013 [NCBI36] Chr3:3q24-26.32	pathogenic
GRCh38/hg38 3q24-29(chr3:147521892-198096565)x3	copy number gain	See cases [RCV000051725]	Chr3:147521892..198096565 [GRCh38] Chr3:147239679..197823436 [GRCh37] Chr3:148722369..199307833 [NCBI36] Chr3:3q24-29	pathogenic
GRCh38/hg38 3q22.3-29(chr3:137126982-198110178)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051723]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051723]\|See cases [RCV000051723]	Chr3:137126982..198110178 [GRCh38] Chr3:136845824..197837049 [GRCh37] Chr3:138328514..199321446 [NCBI36] Chr3:3q22.3-29	pathogenic
GRCh38/hg38 3q13.11-29(chr3:103426882-198110178)x3	copy number gain	See cases [RCV000134948]	Chr3:103426882..198110178 [GRCh38] Chr3:103145726..197837049 [GRCh37] Chr3:104628416..199321446 [NCBI36] Chr3:3q13.11-29	pathogenic
GRCh37/hg19 3q24-29(chr3:142995020-192997215)x4	copy number gain	See cases [RCV000240256]	Chr3:142995020..192997215 [GRCh37] Chr3:3q24-29	pathogenic
GRCh37/hg19 3q24-25.2(chr3:148425748-153220169)x1	copy number loss	See cases [RCV000447056]	Chr3:148425748..153220169 [GRCh37] Chr3:3q24-25.2	pathogenic
GRCh37/hg19 3q24-26.2(chr3:147180945-168415875)x1	copy number loss	See cases [RCV000448130]	Chr3:147180945..168415875 [GRCh37] Chr3:3q24-26.2	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)x3	copy number gain	See cases [RCV000511055]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
NM_001303264.2(TSC22D2):c.620C>T (p.Thr207Ile)	single nucleotide variant	not specified [RCV004300695]	Chr3:150409970 [GRCh38] Chr3:150127757 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.748T>C (p.Ser250Pro)	single nucleotide variant	not specified [RCV004320974]	Chr3:150410098 [GRCh38] Chr3:150127885 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)	copy number gain	See cases [RCV000512358]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:61495-197838262)x3	copy number gain	not provided [RCV000742138]	Chr3:61495..197838262 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:60174-197948027)x3	copy number gain	not provided [RCV000742133]	Chr3:60174..197948027 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3q25.1(chr3:150125489-150128484)x1	copy number loss	not provided [RCV000742881]	Chr3:150125489..150128484 [GRCh37] Chr3:3q25.1	benign
NM_001303264.2(TSC22D2):c.1084C>T (p.Pro362Ser)	single nucleotide variant	not specified [RCV004304130]	Chr3:150410434 [GRCh38] Chr3:150128221 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q25.1-25.2(chr3:149404255-152786331)x1	copy number loss	not provided [RCV001005477]	Chr3:149404255..152786331 [GRCh37] Chr3:3q25.1-25.2	pathogenic
GRCh37/hg19 3q24-25.1(chr3:144053029-150272658)x1	copy number loss	not provided [RCV001005476]	Chr3:144053029..150272658 [GRCh37] Chr3:3q24-25.1	likely pathogenic
GRCh38/hg38 3q25.1(chr3:150462960-150915627)x1	copy number loss	See cases [RCV000053994]	Chr3:150462960..150915627 [GRCh38] Chr3:150180747..150633414 [GRCh37] Chr3:151663437..152116104 [NCBI36] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.761C>T (p.Pro254Leu)	single nucleotide variant	not specified [RCV004297984]	Chr3:150410111 [GRCh38] Chr3:150127898 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q13.31-26.31(chr3:116620308-172042292)x3	copy number gain	not provided [RCV002472621]	Chr3:116620308..172042292 [GRCh37] Chr3:3q13.31-26.31	pathogenic
GRCh37/hg19 3q22.3-26.1(chr3:138145289-162275610)x3	copy number gain	See cases [RCV001194586]	Chr3:138145289..162275610 [GRCh37] Chr3:3q22.3-26.1	pathogenic
GRCh37/hg19 3q22.3-26.1(chr3:138173683-162494699)	copy number gain	Global developmental delay [RCV001352648]	Chr3:138173683..162494699 [GRCh37] Chr3:3q22.3-26.1	pathogenic
GRCh37/hg19 3q24-26.1(chr3:143439359-165252122)x1	copy number loss	not provided [RCV001795847]	Chr3:143439359..165252122 [GRCh37] Chr3:3q24-26.1	pathogenic
GRCh37/hg19 3q23-25.32(chr3:142729607-157921084)x3	copy number gain	Brachycephaly [RCV001801182]	Chr3:142729607..157921084 [GRCh37] Chr3:3q23-25.32	pathogenic
GRCh37/hg19 3q24-25.33(chr3:145486960-160504834)	copy number gain	not specified [RCV002053375]	Chr3:145486960..160504834 [GRCh37] Chr3:3q24-25.33	pathogenic
NC_000003.11:g.(?_148447967)_(151176497_?)del	deletion	Glycogen storage disease XV [RCV003120787]	Chr3:148447967..151176497 [GRCh37] Chr3:3q24-25.1	pathogenic
NM_001303264.2(TSC22D2):c.1702G>T (p.Ala568Ser)	single nucleotide variant	Keratoconus [RCV003235801]	Chr3:150411052 [GRCh38] Chr3:150128839 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.872C>T (p.Pro291Leu)	single nucleotide variant	not specified [RCV004183246]	Chr3:150410222 [GRCh38] Chr3:150128009 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1414C>T (p.Pro472Ser)	single nucleotide variant	not specified [RCV004175057]	Chr3:150410764 [GRCh38] Chr3:150128551 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.414G>C (p.Gln138His)	single nucleotide variant	not specified [RCV004086900]	Chr3:150409764 [GRCh38] Chr3:150127551 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.160G>A (p.Ala54Thr)	single nucleotide variant	not specified [RCV004209702]	Chr3:150409510 [GRCh38] Chr3:150127297 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.2036A>T (p.Tyr679Phe)	single nucleotide variant	not specified [RCV004131184]	Chr3:150458401 [GRCh38] Chr3:150176188 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.788C>T (p.Pro263Leu)	single nucleotide variant	not specified [RCV004111447]	Chr3:150410138 [GRCh38] Chr3:150127925 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.8A>G (p.Lys3Arg)	single nucleotide variant	not specified [RCV004100906]	Chr3:150409358 [GRCh38] Chr3:150127145 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1799C>G (p.Pro600Arg)	single nucleotide variant	not specified [RCV004083937]	Chr3:150411149 [GRCh38] Chr3:150128936 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.955C>T (p.Pro319Ser)	single nucleotide variant	not specified [RCV004155928]	Chr3:150410305 [GRCh38] Chr3:150128092 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.953G>A (p.Gly318Glu)	single nucleotide variant	not specified [RCV004234303]	Chr3:150410303 [GRCh38] Chr3:150128090 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1316C>T (p.Pro439Leu)	single nucleotide variant	not specified [RCV004225509]	Chr3:150410666 [GRCh38] Chr3:150128453 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.337G>C (p.Val113Leu)	single nucleotide variant	not specified [RCV004239690]	Chr3:150409687 [GRCh38] Chr3:150127474 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.230A>T (p.Asp77Val)	single nucleotide variant	not specified [RCV004122369]	Chr3:150409580 [GRCh38] Chr3:150127367 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.391C>G (p.Pro131Ala)	single nucleotide variant	not specified [RCV004202629]	Chr3:150409741 [GRCh38] Chr3:150127528 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1285G>A (p.Ala429Thr)	single nucleotide variant	not provided [RCV004695647]\|not specified [RCV004203598]	Chr3:150410635 [GRCh38] Chr3:150128422 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.317G>T (p.Gly106Val)	single nucleotide variant	not specified [RCV004211149]	Chr3:150409667 [GRCh38] Chr3:150127454 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1472C>A (p.Pro491Gln)	single nucleotide variant	not specified [RCV004078680]	Chr3:150410822 [GRCh38] Chr3:150128609 [GRCh37] Chr3:3q25.1	likely benign
NM_001303264.2(TSC22D2):c.945G>C (p.Gln315His)	single nucleotide variant	not specified [RCV004081707]	Chr3:150410295 [GRCh38] Chr3:150128082 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1574C>A (p.Ser525Tyr)	single nucleotide variant	not specified [RCV004075048]	Chr3:150410924 [GRCh38] Chr3:150128711 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1619A>G (p.Gln540Arg)	single nucleotide variant	not specified [RCV004177524]	Chr3:150410969 [GRCh38] Chr3:150128756 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.353C>A (p.Ala118Asp)	single nucleotide variant	not specified [RCV004076337]	Chr3:150409703 [GRCh38] Chr3:150127490 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1267G>A (p.Gly423Ser)	single nucleotide variant	not specified [RCV004241378]	Chr3:150410617 [GRCh38] Chr3:150128404 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1584G>A (p.Met528Ile)	single nucleotide variant	not specified [RCV004215589]	Chr3:150410934 [GRCh38] Chr3:150128721 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.2246A>G (p.Gln749Arg)	single nucleotide variant	not specified [RCV004268577]	Chr3:150458611 [GRCh38] Chr3:150176398 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.508G>T (p.Gly170Trp)	single nucleotide variant	not specified [RCV004254859]	Chr3:150409858 [GRCh38] Chr3:150127645 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1036G>A (p.Val346Met)	single nucleotide variant	not specified [RCV004261891]	Chr3:150410386 [GRCh38] Chr3:150128173 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1907T>C (p.Leu636Pro)	single nucleotide variant	not specified [RCV004278478]	Chr3:150411257 [GRCh38] Chr3:150129044 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.961G>A (p.Gly321Arg)	single nucleotide variant	not specified [RCV004280254]	Chr3:150410311 [GRCh38] Chr3:150128098 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.977C>G (p.Pro326Arg)	single nucleotide variant	not specified [RCV004251783]	Chr3:150410327 [GRCh38] Chr3:150128114 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.2215G>A (p.Ala739Thr)	single nucleotide variant	not specified [RCV004279681]	Chr3:150458580 [GRCh38] Chr3:150176367 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.731G>C (p.Ser244Thr)	single nucleotide variant	not specified [RCV004260556]	Chr3:150410081 [GRCh38] Chr3:150127868 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1885C>A (p.Gln629Lys)	single nucleotide variant	not specified [RCV004351477]	Chr3:150411235 [GRCh38] Chr3:150129022 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.337G>T (p.Val113Leu)	single nucleotide variant	not specified [RCV004353508]	Chr3:150409687 [GRCh38] Chr3:150127474 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.73A>G (p.Ser25Gly)	single nucleotide variant	not specified [RCV004363706]	Chr3:150409423 [GRCh38] Chr3:150127210 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.652C>T (p.Leu218=)	single nucleotide variant	not provided [RCV003434773]	Chr3:150410002 [GRCh38] Chr3:150127789 [GRCh37] Chr3:3q25.1	likely benign
Single allele	duplication	not provided [RCV003448680]	Chr3:140154329..197847235 [GRCh37] Chr3:3q23-29	pathogenic
NM_001303264.2(TSC22D2):c.366G>A (p.Ala122=)	single nucleotide variant	not provided [RCV003434772]	Chr3:150409716 [GRCh38] Chr3:150127503 [GRCh37] Chr3:3q25.1	likely benign
NM_001303264.2(TSC22D2):c.1071C>G (p.Phe357Leu)	single nucleotide variant	not specified [RCV004476383]	Chr3:150410421 [GRCh38] Chr3:150128208 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1408C>G (p.Leu470Val)	single nucleotide variant	not specified [RCV004476384]	Chr3:150410758 [GRCh38] Chr3:150128545 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1417G>C (p.Ala473Pro)	single nucleotide variant	not specified [RCV004476385]	Chr3:150410767 [GRCh38] Chr3:150128554 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.281T>A (p.Leu94Gln)	single nucleotide variant	not specified [RCV004476387]	Chr3:150409631 [GRCh38] Chr3:150127418 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.392C>G (p.Pro131Arg)	single nucleotide variant	not specified [RCV004476388]	Chr3:150409742 [GRCh38] Chr3:150127529 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.917T>C (p.Met306Thr)	single nucleotide variant	not specified [RCV004476389]	Chr3:150410267 [GRCh38] Chr3:150128054 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1066C>G (p.Gln356Glu)	single nucleotide variant	not specified [RCV004476382]	Chr3:150410416 [GRCh38] Chr3:150128203 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1055A>T (p.Gln352Leu)	single nucleotide variant	not specified [RCV004680361]	Chr3:150410405 [GRCh38] Chr3:150128192 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1550G>A (p.Ser517Asn)	single nucleotide variant	not specified [RCV004680363]	Chr3:150410900 [GRCh38] Chr3:150128687 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.2234C>T (p.Thr745Met)	single nucleotide variant	not specified [RCV004680364]	Chr3:150458599 [GRCh38] Chr3:150176386 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1187C>G (p.Pro396Arg)	single nucleotide variant	not specified [RCV004680365]	Chr3:150410537 [GRCh38] Chr3:150128324 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1046C>T (p.Pro349Leu)	single nucleotide variant	not specified [RCV004680366]	Chr3:150410396 [GRCh38] Chr3:150128183 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.615C>A (p.Ser205Arg)	single nucleotide variant	not specified [RCV004680367]	Chr3:150409965 [GRCh38] Chr3:150127752 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.760C>G (p.Pro254Ala)	single nucleotide variant	not specified [RCV004687778]	Chr3:150410110 [GRCh38] Chr3:150127897 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.239C>A (p.Thr80Asn)	single nucleotide variant	not specified [RCV004680360]	Chr3:150409589 [GRCh38] Chr3:150127376 [GRCh37] Chr3:3q25.1	uncertain significance
GRCh37/hg19 3q24-25.1(chr3:146504503-151662391)x1	copy number loss	not provided [RCV004819285]	Chr3:146504503..151662391 [GRCh37] Chr3:3q24-25.1	likely pathogenic
NM_001303264.2(TSC22D2):c.2225C>T (p.Pro742Leu)	single nucleotide variant	not specified [RCV004883663]	Chr3:150458590 [GRCh38] Chr3:150176377 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.443C>G (p.Thr148Ser)	single nucleotide variant	not specified [RCV004883666]	Chr3:150409793 [GRCh38] Chr3:150127580 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.226G>C (p.Gly76Arg)	single nucleotide variant	not specified [RCV004883671]	Chr3:150409576 [GRCh38] Chr3:150127363 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.768G>C (p.Glu256Asp)	single nucleotide variant	not specified [RCV004883678]	Chr3:150410118 [GRCh38] Chr3:150127905 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1220C>T (p.Thr407Met)	single nucleotide variant	not specified [RCV004883683]	Chr3:150410570 [GRCh38] Chr3:150128357 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.365C>T (p.Ala122Val)	single nucleotide variant	not specified [RCV004883681]	Chr3:150409715 [GRCh38] Chr3:150127502 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.596G>C (p.Gly199Ala)	single nucleotide variant	not specified [RCV004883665]	Chr3:150409946 [GRCh38] Chr3:150127733 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1976T>C (p.Val659Ala)	single nucleotide variant	not specified [RCV004883668]	Chr3:150457093 [GRCh38] Chr3:150174880 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.443C>T (p.Thr148Ile)	single nucleotide variant	not specified [RCV004883669]	Chr3:150409793 [GRCh38] Chr3:150127580 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1459G>A (p.Gly487Ser)	single nucleotide variant	not specified [RCV004883670]	Chr3:150410809 [GRCh38] Chr3:150128596 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1879C>A (p.Pro627Thr)	single nucleotide variant	not specified [RCV004883672]	Chr3:150411229 [GRCh38] Chr3:150129016 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1958+11794C>T	single nucleotide variant	not specified [RCV004883673]	Chr3:150423102 [GRCh38] Chr3:150140889 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.12G>A (p.Met4Ile)	single nucleotide variant	not specified [RCV004883676]	Chr3:150409362 [GRCh38] Chr3:150127149 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.13C>A (p.Pro5Thr)	single nucleotide variant	not specified [RCV004883677]	Chr3:150409363 [GRCh38] Chr3:150127150 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1660A>C (p.Ile554Leu)	single nucleotide variant	not specified [RCV004883682]	Chr3:150411010 [GRCh38] Chr3:150128797 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.2158C>G (p.Gln720Glu)	single nucleotide variant	not specified [RCV004883664]	Chr3:150458523 [GRCh38] Chr3:150176310 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.1588A>G (p.Asn530Asp)	single nucleotide variant	not specified [RCV004883674]	Chr3:150410938 [GRCh38] Chr3:150128725 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.433G>C (p.Gly145Arg)	single nucleotide variant	not specified [RCV004883675]	Chr3:150409783 [GRCh38] Chr3:150127570 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.353C>T (p.Ala118Val)	single nucleotide variant	not specified [RCV004883679]	Chr3:150409703 [GRCh38] Chr3:150127490 [GRCh37] Chr3:3q25.1	uncertain significance
NM_001303264.2(TSC22D2):c.364G>T (p.Ala122Ser)	single nucleotide variant	not specified [RCV004883680]	Chr3:150409714 [GRCh38] Chr3:150127501 [GRCh37] Chr3:3q25.1	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	4379
Count of miRNA genes:	1120
Interacting mature miRNAs:	1441
Transcripts:	ENST00000361136, ENST00000361875, ENST00000460316, ENST00000466814, ENST00000480589, ENST00000485421, ENST00000492828
Prediction methods:	Microtar, Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597067252	GWAS1163326_H	systolic blood pressure QTL GWAS1163326 (human)		0.000008	systolic blood pressure	systolic blood pressure (CMO:0000004)	3	150410605	150410606	Human
597087282	GWAS1183356_H	PR interval QTL GWAS1183356 (human)		2e-09	PR interval	PR interval (CMO:0000233)	3	150459117	150459118	Human
597022290	GWAS1118364_H	TNF-related apoptosis-inducing ligand measurement QTL GWAS1118364 (human)		0.0000003	TNF-related apoptosis-inducing ligand measurement		3	150460475	150460476	Human
1300026	BP36_H	Blood pressure QTL 36 (human)	4.04		Blood pressure	hypertension susceptibility	3	135720453	161720453	Human
596951839	GWAS1071358_H	fasting blood insulin measurement QTL GWAS1071358 (human)		0.000008	fasting blood insulin measurement		3	150410161	150410162	Human
406947823	GWAS596799_H	PR interval QTL GWAS596799 (human)		1e-08	PR interval	PR interval (CMO:0000233)	3	150459117	150459118	Human
597288874	GWAS1384948_H	body weight QTL GWAS1384948 (human)		2e-08	body mass (VT:0001259)	body weight (CMO:0000012)	3	150449357	150449358	Human
407071732	GWAS720708_H	nephrotic syndrome QTL GWAS720708 (human)		0.000009	nephrotic syndrome		3	150452068	150452069	Human
597045089	GWAS1141163_H	Abnormality of refraction QTL GWAS1141163 (human)		1e-10	Abnormality of refraction		3	150456871	150456872	Human
597074127	GWAS1170201_H	Moyamoya disease QTL GWAS1170201 (human)		2e-09	Moyamoya disease		3	150461152	150461153	Human
1298415	BP24_H	Blood pressure QTL 24 (human)	2.9		Blood pressure	hypertension susceptibility	3	135720453	161720453	Human
597297573	GWAS1393647_H	BMI-adjusted hip circumference QTL GWAS1393647 (human)		2e-08	BMI-adjusted hip circumference	hip circumference (CMO:0000014)	3	150416944	150416945	Human
597037737	GWAS1133811_H	high density lipoprotein cholesterol measurement QTL GWAS1133811 (human)		4e-09	high density lipoprotein cholesterol measurement	blood high density lipoprotein cholesterol level (CMO:0000052)	3	150428612	150428613	Human

SHGC-77462

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,142,086 - 150,142,251	UniSTS	GRCh37
Build 36	3	151,624,776 - 151,624,941	RGD	NCBI36
Celera	3	148,555,120 - 148,555,285	RGD
Cytogenetic Map	3	q25.1	UniSTS
HuRef	3	147,515,819 - 147,515,984	UniSTS
TNG Radiation Hybrid Map	3	84817.0	UniSTS
GeneMap99-GB4 RH Map	3	560.7	UniSTS

D20S995

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,177,459 - 150,177,566	UniSTS	GRCh37
Build 36	3	151,660,149 - 151,660,256	RGD	NCBI36
Celera	3	148,590,491 - 148,590,598	RGD
Cytogenetic Map	3	q25.1	UniSTS
HuRef	3	147,551,123 - 147,551,230	UniSTS

SHGC-57438

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,128,785 - 150,128,903	UniSTS	GRCh37
Build 36	3	151,611,475 - 151,611,593	RGD	NCBI36
Celera	3	148,541,821 - 148,541,939	RGD
Cytogenetic Map	3	q25.1	UniSTS
HuRef	3	147,502,519 - 147,502,637	UniSTS
TNG Radiation Hybrid Map	3	84840.0	UniSTS

STS-D20422

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,177,464 - 150,177,587	UniSTS	GRCh37
Build 36	3	151,660,154 - 151,660,277	RGD	NCBI36
Celera	3	148,590,496 - 148,590,619	RGD
Cytogenetic Map	3	q25.1	UniSTS
HuRef	3	147,551,128 - 147,551,251	UniSTS
TNG Radiation Hybrid Map	3	84812.0	UniSTS
GeneMap99-GB4 RH Map	3	550.53	UniSTS
NCBI RH Map	3	1312.4	UniSTS

SHGC-77469

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,152,159 - 150,152,387	UniSTS	GRCh37
Build 36	3	151,634,849 - 151,635,077	RGD	NCBI36
Celera	3	148,565,191 - 148,565,419	RGD
Cytogenetic Map	3	q25.1	UniSTS
TNG Radiation Hybrid Map	3	85774.0	UniSTS
GeneMap99-GB4 RH Map	3	570.22	UniSTS
NCBI RH Map	3	1322.4	UniSTS

AAT071

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	150,163,036 - 150,163,217	UniSTS	GRCh37
Celera	3	148,576,068 - 148,576,249	UniSTS
HuRef	3	147,536,705 - 147,536,886	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2437	2788	2252	4973	1726	2351	5	624	1951	465	2269	7303	6470	53	3734	1	852	1744	1617	175	1


RefSeq Transcripts	NM_001303264	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_014779	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NR_130136	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011513337	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054348584	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_001740388	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_007095779	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_007095780	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_008486869	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XR_008486870	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AA040291	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AB014569	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC018545	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF201290	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF201291	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF201292	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK123861	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK297383	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK297748	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC036355	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC044643	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BU736250	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471052	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068275	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000361875 ⟹ ENSP00000354543

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	150,408,298 - 150,466,422 (+)	Ensembl

Ensembl Acc Id:

ENST00000460316

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	150,456,951 - 150,459,128 (+)	Ensembl

Ensembl Acc Id:

ENST00000466814 ⟹ ENSP00000417747

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	150,411,009 - 150,460,116 (+)	Ensembl

Ensembl Acc Id:

ENST00000480589 ⟹ ENSP00000418149

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	150,410,969 - 150,458,861 (+)	Ensembl

Ensembl Acc Id:

ENST00000485421 ⟹ ENSP00000420689

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	150,411,179 - 150,458,679 (+)	Ensembl

Ensembl Acc Id:

ENST00000492828

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	150,423,039 - 150,423,451 (+)	Ensembl

Ensembl Acc Id:

ENST00000688009 ⟹ ENSP00000510392

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	150,408,298 - 150,466,422 (+)	Ensembl

RefSeq Acc Id:

NM_001303264 ⟹ NP_001290193

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	150,408,298 - 150,466,422 (+)	NCBI
CHM1_1	3	150,089,196 - 150,140,980 (+)	NCBI
T2T-CHM13v2.0	3	153,159,594 - 153,217,686 (+)	NCBI

Sequence:

show sequence

AGTCGGCAGCGGCGGCGGCAGCGGGGCTGCTGCTCCTCCCAGCATCCCTGGCGCGGCCATTTCAGCCCCATCTTGGCCCAGCGGAGGGAGCTGCAGCCGCCGCTTCAGCAGTTTGAATTTCAGTTTCT
TCGGGGTTTAGGAATTGGGCGCACCGAGGAGGAGCCGGAGAAGCCACCACCGCTACCTCACACAGCCGGGGCGCCTCCGGTCCCGTGCCAGCGGTCTGCCGCCGCCGCCCCTCTCTGAGAGAAGCCGC
GAGGGGAGGCCGAGACCGCCGTCGCCGCCCGCCCGCAGGGGTGGTTCCCCCTGTAAGGGGAGGACCGAGCCGGCTTTCCCCTCCCCCAGAGCGGGTTTCCGCCTGAGGCAGTCGACATGTCCCTGGGG
CTGAGCTCCGGCTAGAGCCGGGGAGGGAGGGCCGCCTGCCCGCGCCACAGCCCCACCGCCCGCCCGCGGACCTTCAGCCAGCTCCGGCCCGCGGCTCCCGGCTGAATTAGGCATCTCCGACTCCGGAC
TCGCCGCTCCTTCCCTCAGTCAGAGAGCCCAGCGCTGACGCCGGCACCGGCCTGAGGAGCCCGAGCGGGGCAGCACCGCCCCTCACGCCGCCGCCACCGCCTCCTCCTCCTCCTCTTCGCCCTCCCAC
TCCCACCCCCAGCCAAGGCCTGCTGACCGCGCCGAGCGCCGAGCTGGACTGACCACGGCTGCCCGGAGACGAGAGAGGAAGCAGCCGGCCCGCCCCTGGGTTCGCGCTCTCGCCGCCTCTGAGGGAAT
TGAATTGAGGCGCCGCGGCTGCGAGAGCTAAAAAGGAAGGAGGAGCCGCCGCGGGACTGAGACGGGGGCAGAGCCGAAGAGACCGACACAGAGAAGGAAACGAGGAGGAGGATGTCTCACCGGGCGGC
CAGCGCCTGGATCAGCCCGTGACTCTTAACAGCGGCGGGCCTCAGACCCCAGCGCAGACTCGGACTTTGTCTTTGGGGGCCCGTGCTCTGCCCTCCCCGGTTTCCGACAGGACCCAGAGGAGCCGGCG
TGCCTCTCTGCCCTCCAGCCTTCTTCACCATGTCCAAGATGCCGGCCAAGAAGAAGAGCTGCTTCCAGATCACCAGTGTCACCACGGCCCAGGTGGCCACTAGCATCACCGAGGACACCGAGAGCTTG
GACGACCCGGACGAGTCACGCACAGAGGACGTCTCCTCCGAGATTTTCGACGTCTCTCGGGCCACGGATTATGGCCCTGAGGAGGTCTGCGAGCGCAGCTCTTCCGAAGAGACGCTTAACAATGTTGG
GGATGCGGAGACTCCCGGGACCGTCTCCCCAAACCTCCTCCTAGATGGGCAGCTGGCAGCGGCGGCTGCTGCTCCCGCCAACGGAGGAGGAGTCGTTTCGGCCCGGAGCGTGTCTGGGGCGCTCGCCA
GTACCCTGGCGGCGGCTGCCACTTCGGCCCCCGCCCCCGGAGCACCCGGCGGCCCCCAGCTCGCGGGCTCATCCGCCGGGCCAGTGACTGCAGCCCCATCTCAGCCTCCCACCACATGTAGTTCCCGT
TTTCGCGTGATCAAGCTGGACCACGGGAGCGGAGAGCCCTATAGACGCGGCCGATGGACGTGTATGGAATACTATGAGAGGGATTCAGACAGCAGCGTCCTGACTAGATCCGGGGATTGCATTAGACA
CAGCAGTACTTTTGACCAGACTGCGGAGCGGGACAGCGGCCTGGGCGCCACCGGAGGGTCGGTGGTGGTAGTAGTGGCCTCCATGCAGGGGGCGCACGGGCCCGAGTCGGGAACTGACAGCTCCTTGA
CTGCTGTGTCACAGCTACCCCCGTCGGAGAAAATGAGCCAGCCCACTCCGGCCCAGCCGCAGAGTTTTAGCGTTGGGCAGCCACAGCCGCCGCCGCCACCCGTAGGTGGGGCTGTGGCTCAAAGCTCG
GCTCCGCTGCCGCCGTTCCCGGGAGCCGCGACCGGGCCGCAGCCAATGATGGCAGCCGCGCAGCCCAGCCAGCCCCAGGGAGCGGGGCCCGGGGGACAGACTCTGCCGCCGACGAATGTAACCCTGGC
GCAGCCGGCTATGTCCCTGCCTCCGCAGCCGGGCCCTGCAGTGGGCGCCCCCGCGGCGCAGCAGCCCCAGCAGTTCGCGTATCCTCAGCCTCAGATACCGCCCGGACATTTGCTGCCCGTCCAGCCCT
CCGGCCAGAGTGAGTACCTGCAGCAGCACGTGGCCGGCCTGCAGCCGCCAAGCCCCGCGCAGCCCTCGTCCACCGGCGCCGCAGCGAGCCCCGCCACGGCGGCCACCCTTCCCGTGGGCACCGGCCAG
AATGCTTCCTCGGTGGGCGCGCAGCTCATGGGCGCGTCTTCCCAGCCCAGCGAAGCCATGGCCCCCCGGACGGGACCAGCGCAAGGCGGGCAGGTCGCGCCTTGTCAGCCGACTGGAGTGCCCCCGGC
TACTGTGGGAGGCGTGGTGCAGCCGTGCCTCGGTCCTGCCGGGGCTGGGCAGCCCCAGTCCGTGCCTCCGCCGCAGATGGGTGGCAGTGGTCCGCTGTCAGCCGTACCTGGTGGCCCTCACGCCGTGG
TGCCCGGAGTTCCAAACGTGCCTGCAGCCGTGCCCGCTCCAAGCGTGCCTAGTGTGTCTACCACTTCTGTTACTATGCCAAATGTACCCGCGCCTCTGGCCCAGTCGCAACAGCTGAGCAGCCATACG
CCAGTCAGCAGGAGCAGCAGCATAATCCAGCATGTTGGGCTGCCCTTAGCGCCAGGCACACACAGCGCACCAACAAGTCTACCACAGTCTGACCTAAGCCAGTTTCAAACTCAGACCCAGCCTTTAGT
CGGGCAAGTCGACGATACTAGAAGAAAATCAGAACCCCTACCTCAACCACCACTTTCTCTCATTGCTGAAAATAAGCCTGTTGTGAAGCCGCCTGTTGCAGATTCCCTGGCAAACCCCCTTCAGTTAA
CACCTATGAACAGTCTGGCCACCTCTGTATTCAGCATAGCTATTCCTGTTGATGGTGATGAAGACAGTGCATCTGGGGGAGGTGTTGTAGCCATTGACAACAAAATAGAACAAGCAATGGATCTGGTG
AAAAGCCATTTGATGTATGCAGTAAGAGAAGAAGTGGAAGTTTTAAAGGAACAAATAAAAGAATTAGTTGAAAGAAACTCTTTACTTGAACGAGAAAATGCACTGTTAAAATCTCTTTCAAGCAATGA
TCAATTATCCCAACTCCCAACCCAACAGGCCAATCCTGGTAGCACTTCTCAACAGCAAGCAGTGATAGCACAGCCTCCGCAGCCAACGCAACCTCCACAGCAGCCGAATGTCTCCTCAGCATAAAGCT
TTCTTAAGCCTCATTAAGAAAAAAACTGAAAGCAATCTATCCTTGTGTGCCACTGGTGTTCTTTCCACTTTATACGAAAGCAAGTAGCCATGCTTTGGTTGTGTGTTTGGCCTTTTCAGTATTAGACA
ATCATTCTACAAGAGCTTTTCCTCTCTCTGAGATGTCATGCAGCGCTGTTGATGTCCAGTTCTATGTCATCAGTACACAAGGAGAATAATAGATGGGGTTTATTAAAGCGAGCAAAGTCTGCATTTTA
CCTGGTGCGCATGAGTGGGGTCTTTAAGAGTTTTGGTGGCTCTCCCATGTTTCCTATTACCCATGGATTTACCCTGAGCCTTCCTATCACATTATAAATAACAGTTCATCTAAAGAGCCACTTTTCTT
TCTGATTCAGTAACATTTGCCTACATAAGTTTTCATTTATTTGTGTTTTATTTATTACAGGGCTGCTATTTTCATAATGTACATGAACAATGTCACAGAACTTTTTTAATTTTTTTGAATAATTATAA
GTATCAGTAAAGGAAGTGAAAGACAGGATTGCATTTAATAGATAAAACGTTTAGGCAATAATTGAACAAAAGAATCCTGGCATATTTCTAACACTAATGGCAATTTACTTATGGTATTTATTTTCAGT
AGTAAAGACCCAGCTTGAATGTAAATTTTGTATAGTGTAAGTATGAAGAACATAGTGCAACTGTACAGGTAGTCACCAGTTATTGTGATATGATAAATAATTGGGCTATTTTGATGAAGAAAACTTTG
TTCATTTGTTTCTACTTTCTAAGAGAAATTGCCACGATTCCTCTGCTTTTCAACATTTCGTATGACTTTTTTTTCGGGTGGGAATAAAAAGCTGTGAAATTGTTCAACCTACTTTGTAACCAAAGAAG
CAAAGCTGTGTAATGGAGTTTGGTTTTTTTTTGTTGTTTTTTTTTTTTTGTCTTTTTTTTTTTTTATAATGCACATTCTTTATGTATTTTTATTTAGTGTTTTCTCAGTCACAATTTTCTTTACTGTC
TAGCATGATCTGCATGACCTATAATCTTTGAACCACTTTCGTACCTCATGTTTTTATCCAGCACTCTTATTGTAATATGTACTAGTCTGTGAACAATGTCAAATAAAAGAGAACGAACAGGTAGTTTG
GTGGAGCTGAGCTAGTGTACAATACACTAGTTGTAAAAAAAAAAAAAAAAAAAAGTGAGCCATCTTTTGTTCATTTAAAATGGTGTTTTGAATTTCGTATGCAGAAAACGTTTTGTTACATTGCAGAT
TTTAATGTATTTAATAAATGCAACATGCAGATTAAGTGCAGTGTATACTGAGTATTTAAATTAAAATGTACATTTCATAAATACAGTTTCAAAAGAAAGCATCATTTTGTGTATACTAACACATTAAG
TGTATGTCAGAAATTGATGTATAAATATATATTTTAACATTTTCTGAAATTAAACTGCAGTTTTGTTGAAATATTTGGCTCTATATGTGTTCAAAATTTGACTAGATTTGTATTTTCACAGTTCAAAA
TACTCCTTAAAGACCTGTTAATAATGACTTACTGATAGTTCTTAAATTTTCAAAGTAAAACAATTTAAAGAATGCAAAAATAGTGAGCAATATTTGTACTCAATATTCATATTATGTTAGTGATACTT
AAGTAGGAAATCCTTGTCTACCAAAACTTTTACTTGAATTCAGAAAGGTGCCTGTAGAAATTAACATGCACTGCATCTGTAGCCAGCTAGCTAATCAGAGTTAATGAGAACCAGTAGTTAGTTCTCCG
TGTTAAAAGACTTATTTGAAGTAAAAATTTAATCAGATTAGCCACAAACAAACAAGGCATAAAATTGGGATGTACATGAGATTGCCAAATATTTTCTATTCTAGTTGTGCTGCAAGACATTGAACAAA
ATGTTAATGAATAACATTATAAATCAAGGAACTAAGTACATAGGCTTGAGTAAGCAACCCTAAGGATGTGTAGTAAGATTCCAAGTAGAGCTGCTACAGGTGAGATACTTAATGGAATGTGAAACTTC
ACTGTTGGACTGTTAACCGAAAAGGTTTGCTGGCTGTGCCCCTCCAGTGCTAACTGTGACATGTGATATTTAATACAGGTGGAGAAAAACTAGTCTTAGAAATGGGATTTTTGTGAAAATAGATTCCA
TTTTGATTCTGGGGCTGGAAAAACACTTCATAAACAAAGTAATAGTCTCCAAGGAAATGAATAATAAGGTTTAAAATGGTAACAGCAGTTATTACTACTTTTATATTAAGAAAAACAGTAGAAAAGGA
GAGAAAATATGGGTAGTTCACAGAAGAGATAAATGGCAGTTTCTAAAGGTTCAACCTCTAGTAACCTAAGAAATGCAAATTAATGTTTTTGGCGAATTGTAATAAGTGTCCTAAGTAGCAGGACTTAA
CATAGAAAGAAAGACAGGCTTTCCTGTGTACTTTTAGAAAGTAATTTGGCAGTATGTATCTAGAGCCTTAAATAATAAGCTTTCCAGTGTAACGACAGGAGAAGATACTCAACTCATGGTCCATTGTT
CAAAAATGCAGAATTATTGTGGTGTCTGCCCTCTGCTTTCCCATCATCCCCTCCCCTCAAAATCCAAACTATCCCTACTGTCAACCCTTCCCCCAGCTGATTGTTTAGGATCTTAAGTAACTTCCAAT
TCAGCTTTGGAGATTTAGTCTCCTGCTCCAAATAGTTGTAAATATTAACTGATTGAGATCCCAATTTGGAGGCACAGTCTTACAGGAATGCCATCTATCTAATTCTGTCAGTGTAATGCCCATAGAGC
AAGGTCCCACATAAGCTTTTCTGTTTTAATTTAGCCGGTAAATCATAAGTAGAAATTTTTCTGATACGGTAATTGTCTACAATTCAAACCTAACTTTCCCCAAATAAAATTTAGTTTGTTCCGATGTG
ATCTCACAGCTTGCCACACCAAAAACAAATAGTAGGGGTTAGGAGGCATTAAATAAACAGTTTCCTTAACTCCTGATTGTCCAAAATAGCTGAATTTTTCCAATTCTATTTATAATATCCTATGCTAA
TTAGAAGTATTGAGATAACGTTTTATAATCAAGCCTCCAGTGACTGGGGATCACAGCTGCCATTATTCACAAGAATTTTCACAGGTGAATGATTATATTTCTCCAAGTTGCAAACTCCAGTAATTCAT
GGACCTTTTTTTAAAAAAAAAAAAAGTCTTAATAGAACCAGAATATCTCTGTTCTTGAAAATTTATCTTTGCAGAACCAGAAATAGCTAATTGTCTGGAAACAATTTTTAAGATTTGAAGTCACATTT
TTAAAAGAAGCTTTATGGCTCAGTGGCAAGCACTTTGTGACATTTCTTTAATAATCCTATGAAAAGGACAAAACCCAGCCCTCAAAATTGACAATTTGAGGACATAATAAGCCAACTGATAATGCAGT
GAGGAATACTTGTTACTATGTACAGTCAGGGATGGTTTTGTCAGGGTAGGTTTCCTCAAAAACATGACACCTGAGTCTTGAAGGTCATAAGAGCCAGAGGGAAGGGTGTTCCAAGCACAAGAAAAGAG
AACTCAATGGCTTAAAAGTATAAACAAGGCTCCTAGGGCAGCCACAGAATTGCATTGGAGACAGGCAGGCAGTGACTTCCCCACTGACCTAGTATTTTGGCATCTATTCAGAAAGCAAGAATGATTTA
TTGAATGGTTTTAAGCAATGGGATACTATGCTCAAATTATGCTGGATGTGCACAATTCCAGTGGCAGATGGGAGGTAGGTTAGAGTAGCTGAAACTGGAAGCTGAGAAATAATTTAGGAGGGATGACA
ATCCGGAAAATAAATGAAAGGGCAAAATTACATAGGCAATTTTGTGAAGGTCATGAAGGAAGTTTGTCTTGGGTCTTTCTGTACCATTTTCCTCTCCACAATGAACATCCCATTCCCAGTGTCAGGTA
TCAGGTGCCTATTTTCTTTTTTTCTTTTTTCTTTTTTTTTTTTTTTGAGACAGAGTCTTGCTGTGCTCAGGCTGGAGTGCAGTGGCAAGATCTCGGCTCACTGCAACCTCCGCCTCCCAGGTTCAAGC
GATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGCGTGTGCCACCATGCCAGGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCACCATGTTGGCCAGGTTGGTCTTGAACTCCTGAC
CTCAAGTCATCTCCCCCGCCCGCCTGGGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGCACCCAGCTGCCTATTTTCTTGTCCCTCCAAAAAAAGATTAAAGAGTCCCAACTCATACTTGA
AAGTTTGACTCGGTCTTTTCCTTCCAACAGTTATAAATCTGTGAAATGAAAGTCTTTGTTTCCTTAAAGGGATTTCAAGAATTTAACAAAAGGGTTGGGGAATGGAACCTTTGCTGTCACTATGCCTG
TCTCTCAATTCTACCCTAAAGGTAAACTAAATGGAATCCTTTTATGGTGACTAGGATTAGGATGTTGATTCCAAAGCCTTTCCCTAAAATCTATTCCTTGCTCCCTGGAAAGGATAATACAGGTTCTG
GCCCCCACTGTAGGTACTGACAGCCCAAGGCAGAATAGGTTTTGCTAGGCTTTAGCCTTTTATTCTTTGACATAGGTCAGTCCTGCAGGCTTCTTTTTTCTAAGTCTCCTGCCTATCCAAAACCAGAC
CTTTTCTCCCACCTCCTTCTGCTTCAAGCCTCTTAATAATCCATATTTCTATTTTCTAGCAATAGTAATAGTTTATTATTTAGTGATGTATACTTGCACCCCATTTACTCCTTTTCAATATTTCAGGA
TACATCTTTGTCCTGTATTTCTGTACCAGTTCACAGAATTTCTACAGCAAGATCCCTTTAAATGTATGGCTTTCCTTCATAGGTTGCAAGGATTACTTTATACAAGTGCTACTGTAACTATATCTTTT
GTGGAGTACAATTGGTATGACATGCTGTGTTCATAGATGAAAATGCTAAGTGAGGCACTCTGAAGCAAGTTAAAGTTCACAGACATTCTTGCTTGCCCACCACCCCCCCGAACCCCGCCATGGAATCA
TCAAATAAGAAAAATAAGACAGATTTTCAGATTGGTGATGGCAAAGTAAGACGCTGGTATTTTGCACTGGCGCAGTCCATTTAGTTGTTGAATTTGTTCAGCATACCTGGATGGTGAGTGAGTTAGCT
TTATTTTTCATTCTCAGCAGGGAAACTGATAGACTAGGCAGTTTGGGGAATTTTCCCATTGTCTACTGTCATGGGTCCATAGTATTTAAGTTTACAGACTACAACATTGTCCACAGAAGCCATATTTA
TCCCCTTGGAGGGAAGGGAAAGGTGTGCTAACTTAGATCATAAAAACAACTGAATTTTAAAACAAGGCAAATGCCACAGTTCAACTTCTCCATAAAAAAGTTAAGTTCATCTCTCCATTCTTTTGCAT
GCCTACAATATTTCCATATAACAACTGTAAAATACTCTTGCCTGCTGCAATCCAAATGTTATCCGGATCACAGTTCTTGCTGTCATTTCACAGGCATGCAATGTATCTATAGATAGGTCATATCATAC
CTGAGGAAGATCAGAGACAGCAAGGGAACATTTTCCCCACACTTGAGATGGAAATAATAACAGGTCAGTGGCTAATAAAAAGAAACATGTATGACTTTGTAAAACCCTAAAAGTGATGTTTTCAAGAA
ATTTAGGTTTCTTTTTTTTATTTTATAAAAAAAATGTTGACATGCAATTTAATTCTATTTCAATTTAGGTGCTGCAACCTGTACTGGATGTTTGGGGATAGAAAGATGAATGGGACATGATTTGTGTG
CTCCAATGAGCTCAGTCCAGTGTAAGTGTAAAAGTTAAAGTGCCATATTGTTTATTCAGAGTATATGTTATAGTTTGTGAACCTTATATCATTTGTTAAATGAAAGGTTTTTATAAATCAACAGTAAT
ATTGCCATCCCATGTAAAAATCCTTTGATATTGCCAGGAAACAACTTTAAATCACCAGAAAGCTTTAACATCAAATAATACTTTTAGAAGGAGGGGAAAAGCCTTCCACCTCGACATCGAGCCTATGA
AGTATTCCCTAAAAAAGAGGAACTAATCTGAGAAAAGTTTACACATTTTTAATACTCTAAGTTGTAGATAATGAAATTGATTTAAATCAAAGTTAACTAGAATAGGATTCATGTGTCATGAATTATAT
TGTCTATTGTCTCATAAGCAACAAGTGACACTTATTATCTTGGCTGACAAAATCAGCTACCATTTAATGAACCAAGTTAAGAATAACTCAGGTGACTGATACCAAAAATAAATCTCTAATACAGCTGA
GAATCCAGAAACACAAATAATATGTTGAGTAAGTAATAAAAGTGACATTTCAAATTAGTAAGGAAAAAATGGATTATTCAACAAATAGTATGGGATAGCATAACAATTTAGAAGAAATATAAAGTTAG
ATCTTTCACAAAAATTAATTCTAGCTAGACTAGCAGTTAGTCTTCTACTTTTTGGTTACTCCCTTTTAGAAATTGGAAGCTATGAAGCTATATACCCTGTCCATTTGAAAATGCACATAAGCAAAGAA
CTTTACAAATAGGTTATAAAGAGAAGCTCAATCTCAGCAAAATAAGGGAAGTGCACATTAAAACACAAGAAACCATCTCAGATCCAACTAATATTTAGCGTGCATACAAATCAAAAGCTGGAAAGGGT
GTGGAAAAACAGGAATACATTGCTAGTGAGCATACAAATTGGCACAGCCTCTTTTAAAGACAATTGTGTATCACCCATTAAATTTTAAAAGTCACATACCCTGTGACCTAACAATTCCAACTTTTAAT
GTCCTAAAGAAACATACATGTGTTCACAAGATAGCCTGTACAATGATGTCAATTGCACCTTTGCTTGTACAGTAGACCCCCTTATCTGCATTTTCACTTTTTGAGGTTTCAGTCATCCAAGGTCAACC
ACAATACAAAAATATTAAATGGAAAATTCCAGAAACGAACATAAGTTTTAAACTTCAAACCTTTCTGCATAGTATAATAAAAATCTCTCACTATCCCTCTCCATCCTGCCTGGGACAGGAATCATCCC
TTTGTCCAGTGTATCCACAATGTATACACTCATTATATACCCATTTTATAATGCCCATTAGTCATTTCTATTATCAGATCATAAAAAAACATAGTACATAGAGGGTTTGGTATTATTCATGGTTTCAG
GCATTCAGTGAGGGTCTTGGAAAATATCCTCCATGATGGGGGAGCTACTGTAATACTATGAAATTGGAAAAACCAAAATACTCATCAAGAGGATGGACTATGGTACACATGATGAAGTATTAAGTATC
AATGAAAAAGAGAGAGTCCTACATGTCCGGCATGGAAGGATCTCCAGGAGACAATGTTAAAAGTTTGGGGGAAAAATTGAAAGACAATACCTGTAATACATATGATACTAGTGATGTTAAATCACATC
ACACACACACACACACACACACACACACACACACAAATACTGTATAGTGTACTTCTACAAGTACATATTTGTGTATTATATAGAGAGAAGGTCTGGAAGGATACTAACCAAACTGTCAACAGTAGTTT
GGTAGCGTGCATTAGCTTTAACTGTAATGTTTGATGTTTTTGAATATGCATTTATGTATTGTTTGTGTAATGACAAATTAATAAATTAGAAATAAAATAAAA

hide sequence

RefSeq Acc Id:

NM_014779 ⟹ NP_055594

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	150,408,298 - 150,466,422 (+)	NCBI
GRCh37	3	150,126,101 - 150,177,906 (+)	NCBI
Build 36	3	151,609,478 - 151,660,321 (+)	NCBI Archive
Celera	3	148,539,824 - 148,590,663 (+)	RGD
HuRef	3	147,500,522 - 147,551,293 (+)	ENTREZGENE
CHM1_1	3	150,089,196 - 150,140,980 (+)	NCBI
T2T-CHM13v2.0	3	153,159,594 - 153,217,686 (+)	NCBI

Sequence:

show sequence

AGTCGGCAGCGGCGGCGGCAGCGGGGCTGCTGCTCCTCCCAGCATCCCTGGCGCGGCCATTTCAGCCCCATCTTGGCCCAGCGGAGGGAGCTGCAGCCGCCGCTTCAGCAGTTTGAATTTCAGTTTCT
TCGGGGTTTAGGAATTGGGCGCACCGAGGAGGAGCCGGAGAAGCCACCACCGCTACCTCACACAGCCGGGGCGCCTCCGGTCCCGTGCCAGCGGTCTGCCGCCGCCGCCCCTCTCTGAGAGAAGCCGC
GAGGGGAGGCCGAGACCGCCGTCGCCGCCCGCCCGCAGGGGTGGTTCCCCCTGTAAGGGGAGGACCGAGCCGGCTTTCCCCTCCCCCAGAGCGGGTTTCCGCCTGAGGCAGTCGACATGTCCCTGGGG
CTGAGCTCCGGCTAGAGCCGGGGAGGGAGGGCCGCCTGCCCGCGCCACAGCCCCACCGCCCGCCCGCGGACCTTCAGCCAGCTCCGGCCCGCGGCTCCCGGCTGAATTAGGCATCTCCGACTCCGGAC
TCGCCGCTCCTTCCCTCAGTCAGAGAGCCCAGCGCTGACGCCGGCACCGGCCTGAGGAGCCCGAGCGGGGCAGCACCGCCCCTCACGCCGCCGCCACCGCCTCCTCCTCCTCCTCTTCGCCCTCCCAC
TCCCACCCCCAGCCAAGGCCTGCTGACCGCGCCGAGCGCCGAGCTGGACTGACCACGGCTGCCCGGAGACGAGAGAGGAAGCAGCCGGCCCGCCCCTGGGTTCGCGCTCTCGCCGCCTCTGAGGGAAT
TGAATTGAGGCGCCGCGGCTGCGAGAGCTAAAAAGGAAGGAGGAGCCGCCGCGGGACTGAGACGGGGGCAGAGCCGAAGAGACCGACACAGAGAAGGAAACGAGGAGGAGGATGTCTCACCGGGCGGC
CAGCGCCTGGATCAGCCCGTGACTCTTAACAGCGGCGGGCCTCAGACCCCAGCGCAGACTCGGACTTTGTCTTTGGGGGCCCGTGCTCTGCCCTCCCCGGTTTCCGACAGGACCCAGAGGAGCCGGCG
TGCCTCTCTGCCCTCCAGCCTTCTTCACCATGTCCAAGATGCCGGCCAAGAAGAAGAGCTGCTTCCAGATCACCAGTGTCACCACGGCCCAGGTGGCCACTAGCATCACCGAGGACACCGAGAGCTTG
GACGACCCGGACGAGTCACGCACAGAGGACGTCTCCTCCGAGATTTTCGACGTCTCTCGGGCCACGGATTATGGCCCTGAGGAGGTCTGCGAGCGCAGCTCTTCCGAAGAGACGCTTAACAATGTTGG
GGATGCGGAGACTCCCGGGACCGTCTCCCCAAACCTCCTCCTAGATGGGCAGCTGGCAGCGGCGGCTGCTGCTCCCGCCAACGGAGGAGGAGTCGTTTCGGCCCGGAGCGTGTCTGGGGCGCTCGCCA
GTACCCTGGCGGCGGCTGCCACTTCGGCCCCCGCCCCCGGAGCACCCGGCGGCCCCCAGCTCGCGGGCTCATCCGCCGGGCCAGTGACTGCAGCCCCATCTCAGCCTCCCACCACATGTAGTTCCCGT
TTTCGCGTGATCAAGCTGGACCACGGGAGCGGAGAGCCCTATAGACGCGGCCGATGGACGTGTATGGAATACTATGAGAGGGATTCAGACAGCAGCGTCCTGACTAGATCCGGGGATTGCATTAGACA
CAGCAGTACTTTTGACCAGACTGCGGAGCGGGACAGCGGCCTGGGCGCCACCGGAGGGTCGGTGGTGGTAGTAGTGGCCTCCATGCAGGGGGCGCACGGGCCCGAGTCGGGAACTGACAGCTCCTTGA
CTGCTGTGTCACAGCTACCCCCGTCGGAGAAAATGAGCCAGCCCACTCCGGCCCAGCCGCAGAGTTTTAGCGTTGGGCAGCCACAGCCGCCGCCGCCACCCGTAGGTGGGGCTGTGGCTCAAAGCTCG
GCTCCGCTGCCGCCGTTCCCGGGAGCCGCGACCGGGCCGCAGCCAATGATGGCAGCCGCGCAGCCCAGCCAGCCCCAGGGAGCGGGGCCCGGGGGACAGACTCTGCCGCCGACGAATGTAACCCTGGC
GCAGCCGGCTATGTCCCTGCCTCCGCAGCCGGGCCCTGCAGTGGGCGCCCCCGCGGCGCAGCAGCCCCAGCAGTTCGCGTATCCTCAGCCTCAGATACCGCCCGGACATTTGCTGCCCGTCCAGCCCT
CCGGCCAGAGTGAGTACCTGCAGCAGCACGTGGCCGGCCTGCAGCCGCCAAGCCCCGCGCAGCCCTCGTCCACCGGCGCCGCAGCGAGCCCCGCCACGGCGGCCACCCTTCCCGTGGGCACCGGCCAG
AATGCTTCCTCGGTGGGCGCGCAGCTCATGGGCGCGTCTTCCCAGCCCAGCGAAGCCATGGCCCCCCGGACGGGACCAGCGCAAGGCGGGCAGGTCGCGCCTTGTCAGCCGACTGGAGTGCCCCCGGC
TACTGTGGGAGGCGTGGTGCAGCCGTGCCTCGGTCCTGCCGGGGCTGGGCAGCCCCAGTCCGTGCCTCCGCCGCAGATGGGTGGCAGTGGTCCGCTGTCAGCCGTACCTGGTGGCCCTCACGCCGTGG
TGCCCGGAGTTCCAAACGTGCCTGCAGCCGTGCCCGCTCCAAGCGTGCCTAGTGTGTCTACCACTTCTGTTACTATGCCAAATGTACCCGCGCCTCTGGCCCAGTCGCAACAGCTGAGCAGCCATACG
CCAGTCAGCAGGAGCAGCAGCATAATCCAGCATGTTGGGCTGCCCTTAGCGCCAGGCACACACAGCGCACCAACAAGTCTACCACAGTCTGACCTAAGCCAGTTTCAAACTCAGACCCAGCCTTTAGT
CGGGCAAGTCGACGATACTAGAAGAAAATCAGAACCCCTACCTCAACCACCACTTTCTCTCATTGCTGAAAATAAGCCTGTTGTGAAGCCGCCTGTTGCAGATTCCCTGGCAAACCCCCTTCAGTTAA
CACCTATGAACAGTCTGGCCACCTCTGTATTCAGCATAGCTATTCCTGTTGATGGTGATGAAGACAGGAATCCTTCAACTGCTTTCTACCAAGCGTTCCATTTGAACACGTTAAAGGAATCAAAGAGC
CTCTGGGATAGTGCATCTGGGGGAGGTGTTGTAGCCATTGACAACAAAATAGAACAAGCAATGGATCTGGTGAAAAGCCATTTGATGTATGCAGTAAGAGAAGAAGTGGAAGTTTTAAAGGAACAAAT
AAAAGAATTAGTTGAAAGAAACTCTTTACTTGAACGAGAAAATGCACTGTTAAAATCTCTTTCAAGCAATGATCAATTATCCCAACTCCCAACCCAACAGGCCAATCCTGGTAGCACTTCTCAACAGC
AAGCAGTGATAGCACAGCCTCCGCAGCCAACGCAACCTCCACAGCAGCCGAATGTCTCCTCAGCATAAAGCTTTCTTAAGCCTCATTAAGAAAAAAACTGAAAGCAATCTATCCTTGTGTGCCACTGG
TGTTCTTTCCACTTTATACGAAAGCAAGTAGCCATGCTTTGGTTGTGTGTTTGGCCTTTTCAGTATTAGACAATCATTCTACAAGAGCTTTTCCTCTCTCTGAGATGTCATGCAGCGCTGTTGATGTC
CAGTTCTATGTCATCAGTACACAAGGAGAATAATAGATGGGGTTTATTAAAGCGAGCAAAGTCTGCATTTTACCTGGTGCGCATGAGTGGGGTCTTTAAGAGTTTTGGTGGCTCTCCCATGTTTCCTA
TTACCCATGGATTTACCCTGAGCCTTCCTATCACATTATAAATAACAGTTCATCTAAAGAGCCACTTTTCTTTCTGATTCAGTAACATTTGCCTACATAAGTTTTCATTTATTTGTGTTTTATTTATT
ACAGGGCTGCTATTTTCATAATGTACATGAACAATGTCACAGAACTTTTTTAATTTTTTTGAATAATTATAAGTATCAGTAAAGGAAGTGAAAGACAGGATTGCATTTAATAGATAAAACGTTTAGGC
AATAATTGAACAAAAGAATCCTGGCATATTTCTAACACTAATGGCAATTTACTTATGGTATTTATTTTCAGTAGTAAAGACCCAGCTTGAATGTAAATTTTGTATAGTGTAAGTATGAAGAACATAGT
GCAACTGTACAGGTAGTCACCAGTTATTGTGATATGATAAATAATTGGGCTATTTTGATGAAGAAAACTTTGTTCATTTGTTTCTACTTTCTAAGAGAAATTGCCACGATTCCTCTGCTTTTCAACAT
TTCGTATGACTTTTTTTTCGGGTGGGAATAAAAAGCTGTGAAATTGTTCAACCTACTTTGTAACCAAAGAAGCAAAGCTGTGTAATGGAGTTTGGTTTTTTTTTGTTGTTTTTTTTTTTTTGTCTTTT
TTTTTTTTTATAATGCACATTCTTTATGTATTTTTATTTAGTGTTTTCTCAGTCACAATTTTCTTTACTGTCTAGCATGATCTGCATGACCTATAATCTTTGAACCACTTTCGTACCTCATGTTTTTA
TCCAGCACTCTTATTGTAATATGTACTAGTCTGTGAACAATGTCAAATAAAAGAGAACGAACAGGTAGTTTGGTGGAGCTGAGCTAGTGTACAATACACTAGTTGTAAAAAAAAAAAAAAAAAAAAGT
GAGCCATCTTTTGTTCATTTAAAATGGTGTTTTGAATTTCGTATGCAGAAAACGTTTTGTTACATTGCAGATTTTAATGTATTTAATAAATGCAACATGCAGATTAAGTGCAGTGTATACTGAGTATT
TAAATTAAAATGTACATTTCATAAATACAGTTTCAAAAGAAAGCATCATTTTGTGTATACTAACACATTAAGTGTATGTCAGAAATTGATGTATAAATATATATTTTAACATTTTCTGAAATTAAACT
GCAGTTTTGTTGAAATATTTGGCTCTATATGTGTTCAAAATTTGACTAGATTTGTATTTTCACAGTTCAAAATACTCCTTAAAGACCTGTTAATAATGACTTACTGATAGTTCTTAAATTTTCAAAGT
AAAACAATTTAAAGAATGCAAAAATAGTGAGCAATATTTGTACTCAATATTCATATTATGTTAGTGATACTTAAGTAGGAAATCCTTGTCTACCAAAACTTTTACTTGAATTCAGAAAGGTGCCTGTA
GAAATTAACATGCACTGCATCTGTAGCCAGCTAGCTAATCAGAGTTAATGAGAACCAGTAGTTAGTTCTCCGTGTTAAAAGACTTATTTGAAGTAAAAATTTAATCAGATTAGCCACAAACAAACAAG
GCATAAAATTGGGATGTACATGAGATTGCCAAATATTTTCTATTCTAGTTGTGCTGCAAGACATTGAACAAAATGTTAATGAATAACATTATAAATCAAGGAACTAAGTACATAGGCTTGAGTAAGCA
ACCCTAAGGATGTGTAGTAAGATTCCAAGTAGAGCTGCTACAGGTGAGATACTTAATGGAATGTGAAACTTCACTGTTGGACTGTTAACCGAAAAGGTTTGCTGGCTGTGCCCCTCCAGTGCTAACTG
TGACATGTGATATTTAATACAGGTGGAGAAAAACTAGTCTTAGAAATGGGATTTTTGTGAAAATAGATTCCATTTTGATTCTGGGGCTGGAAAAACACTTCATAAACAAAGTAATAGTCTCCAAGGAA
ATGAATAATAAGGTTTAAAATGGTAACAGCAGTTATTACTACTTTTATATTAAGAAAAACAGTAGAAAAGGAGAGAAAATATGGGTAGTTCACAGAAGAGATAAATGGCAGTTTCTAAAGGTTCAACC
TCTAGTAACCTAAGAAATGCAAATTAATGTTTTTGGCGAATTGTAATAAGTGTCCTAAGTAGCAGGACTTAACATAGAAAGAAAGACAGGCTTTCCTGTGTACTTTTAGAAAGTAATTTGGCAGTATG
TATCTAGAGCCTTAAATAATAAGCTTTCCAGTGTAACGACAGGAGAAGATACTCAACTCATGGTCCATTGTTCAAAAATGCAGAATTATTGTGGTGTCTGCCCTCTGCTTTCCCATCATCCCCTCCCC
TCAAAATCCAAACTATCCCTACTGTCAACCCTTCCCCCAGCTGATTGTTTAGGATCTTAAGTAACTTCCAATTCAGCTTTGGAGATTTAGTCTCCTGCTCCAAATAGTTGTAAATATTAACTGATTGA
GATCCCAATTTGGAGGCACAGTCTTACAGGAATGCCATCTATCTAATTCTGTCAGTGTAATGCCCATAGAGCAAGGTCCCACATAAGCTTTTCTGTTTTAATTTAGCCGGTAAATCATAAGTAGAAAT
TTTTCTGATACGGTAATTGTCTACAATTCAAACCTAACTTTCCCCAAATAAAATTTAGTTTGTTCCGATGTGATCTCACAGCTTGCCACACCAAAAACAAATAGTAGGGGTTAGGAGGCATTAAATAA
ACAGTTTCCTTAACTCCTGATTGTCCAAAATAGCTGAATTTTTCCAATTCTATTTATAATATCCTATGCTAATTAGAAGTATTGAGATAACGTTTTATAATCAAGCCTCCAGTGACTGGGGATCACAG
CTGCCATTATTCACAAGAATTTTCACAGGTGAATGATTATATTTCTCCAAGTTGCAAACTCCAGTAATTCATGGACCTTTTTTTAAAAAAAAAAAAAGTCTTAATAGAACCAGAATATCTCTGTTCTT
GAAAATTTATCTTTGCAGAACCAGAAATAGCTAATTGTCTGGAAACAATTTTTAAGATTTGAAGTCACATTTTTAAAAGAAGCTTTATGGCTCAGTGGCAAGCACTTTGTGACATTTCTTTAATAATC
CTATGAAAAGGACAAAACCCAGCCCTCAAAATTGACAATTTGAGGACATAATAAGCCAACTGATAATGCAGTGAGGAATACTTGTTACTATGTACAGTCAGGGATGGTTTTGTCAGGGTAGGTTTCCT
CAAAAACATGACACCTGAGTCTTGAAGGTCATAAGAGCCAGAGGGAAGGGTGTTCCAAGCACAAGAAAAGAGAACTCAATGGCTTAAAAGTATAAACAAGGCTCCTAGGGCAGCCACAGAATTGCATT
GGAGACAGGCAGGCAGTGACTTCCCCACTGACCTAGTATTTTGGCATCTATTCAGAAAGCAAGAATGATTTATTGAATGGTTTTAAGCAATGGGATACTATGCTCAAATTATGCTGGATGTGCACAAT
TCCAGTGGCAGATGGGAGGTAGGTTAGAGTAGCTGAAACTGGAAGCTGAGAAATAATTTAGGAGGGATGACAATCCGGAAAATAAATGAAAGGGCAAAATTACATAGGCAATTTTGTGAAGGTCATGA
AGGAAGTTTGTCTTGGGTCTTTCTGTACCATTTTCCTCTCCACAATGAACATCCCATTCCCAGTGTCAGGTATCAGGTGCCTATTTTCTTTTTTTCTTTTTTCTTTTTTTTTTTTTTTGAGACAGAGT
CTTGCTGTGCTCAGGCTGGAGTGCAGTGGCAAGATCTCGGCTCACTGCAACCTCCGCCTCCCAGGTTCAAGCGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGCGTGTGCCACCATGC
CAGGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCACCATGTTGGCCAGGTTGGTCTTGAACTCCTGACCTCAAGTCATCTCCCCCGCCCGCCTGGGCCTCCCAAAGTGTTGGGATTACAGGCGT
GAGCCACCGCACCCAGCTGCCTATTTTCTTGTCCCTCCAAAAAAAGATTAAAGAGTCCCAACTCATACTTGAAAGTTTGACTCGGTCTTTTCCTTCCAACAGTTATAAATCTGTGAAATGAAAGTCTT
TGTTTCCTTAAAGGGATTTCAAGAATTTAACAAAAGGGTTGGGGAATGGAACCTTTGCTGTCACTATGCCTGTCTCTCAATTCTACCCTAAAGGTAAACTAAATGGAATCCTTTTATGGTGACTAGGA
TTAGGATGTTGATTCCAAAGCCTTTCCCTAAAATCTATTCCTTGCTCCCTGGAAAGGATAATACAGGTTCTGGCCCCCACTGTAGGTACTGACAGCCCAAGGCAGAATAGGTTTTGCTAGGCTTTAGC
CTTTTATTCTTTGACATAGGTCAGTCCTGCAGGCTTCTTTTTTCTAAGTCTCCTGCCTATCCAAAACCAGACCTTTTCTCCCACCTCCTTCTGCTTCAAGCCTCTTAATAATCCATATTTCTATTTTC
TAGCAATAGTAATAGTTTATTATTTAGTGATGTATACTTGCACCCCATTTACTCCTTTTCAATATTTCAGGATACATCTTTGTCCTGTATTTCTGTACCAGTTCACAGAATTTCTACAGCAAGATCCC
TTTAAATGTATGGCTTTCCTTCATAGGTTGCAAGGATTACTTTATACAAGTGCTACTGTAACTATATCTTTTGTGGAGTACAATTGGTATGACATGCTGTGTTCATAGATGAAAATGCTAAGTGAGGC
ACTCTGAAGCAAGTTAAAGTTCACAGACATTCTTGCTTGCCCACCACCCCCCCGAACCCCGCCATGGAATCATCAAATAAGAAAAATAAGACAGATTTTCAGATTGGTGATGGCAAAGTAAGACGCTG
GTATTTTGCACTGGCGCAGTCCATTTAGTTGTTGAATTTGTTCAGCATACCTGGATGGTGAGTGAGTTAGCTTTATTTTTCATTCTCAGCAGGGAAACTGATAGACTAGGCAGTTTGGGGAATTTTCC
CATTGTCTACTGTCATGGGTCCATAGTATTTAAGTTTACAGACTACAACATTGTCCACAGAAGCCATATTTATCCCCTTGGAGGGAAGGGAAAGGTGTGCTAACTTAGATCATAAAAACAACTGAATT
TTAAAACAAGGCAAATGCCACAGTTCAACTTCTCCATAAAAAAGTTAAGTTCATCTCTCCATTCTTTTGCATGCCTACAATATTTCCATATAACAACTGTAAAATACTCTTGCCTGCTGCAATCCAAA
TGTTATCCGGATCACAGTTCTTGCTGTCATTTCACAGGCATGCAATGTATCTATAGATAGGTCATATCATACCTGAGGAAGATCAGAGACAGCAAGGGAACATTTTCCCCACACTTGAGATGGAAATA
ATAACAGGTCAGTGGCTAATAAAAAGAAACATGTATGACTTTGTAAAACCCTAAAAGTGATGTTTTCAAGAAATTTAGGTTTCTTTTTTTTATTTTATAAAAAAAATGTTGACATGCAATTTAATTCT
ATTTCAATTTAGGTGCTGCAACCTGTACTGGATGTTTGGGGATAGAAAGATGAATGGGACATGATTTGTGTGCTCCAATGAGCTCAGTCCAGTGTAAGTGTAAAAGTTAAAGTGCCATATTGTTTATT
CAGAGTATATGTTATAGTTTGTGAACCTTATATCATTTGTTAAATGAAAGGTTTTTATAAATCAACAGTAATATTGCCATCCCATGTAAAAATCCTTTGATATTGCCAGGAAACAACTTTAAATCACC
AGAAAGCTTTAACATCAAATAATACTTTTAGAAGGAGGGGAAAAGCCTTCCACCTCGACATCGAGCCTATGAAGTATTCCCTAAAAAAGAGGAACTAATCTGAGAAAAGTTTACACATTTTTAATACT
CTAAGTTGTAGATAATGAAATTGATTTAAATCAAAGTTAACTAGAATAGGATTCATGTGTCATGAATTATATTGTCTATTGTCTCATAAGCAACAAGTGACACTTATTATCTTGGCTGACAAAATCAG
CTACCATTTAATGAACCAAGTTAAGAATAACTCAGGTGACTGATACCAAAAATAAATCTCTAATACAGCTGAGAATCCAGAAACACAAATAATATGTTGAGTAAGTAATAAAAGTGACATTTCAAATT
AGTAAGGAAAAAATGGATTATTCAACAAATAGTATGGGATAGCATAACAATTTAGAAGAAATATAAAGTTAGATCTTTCACAAAAATTAATTCTAGCTAGACTAGCAGTTAGTCTTCTACTTTTTGGT
TACTCCCTTTTAGAAATTGGAAGCTATGAAGCTATATACCCTGTCCATTTGAAAATGCACATAAGCAAAGAACTTTACAAATAGGTTATAAAGAGAAGCTCAATCTCAGCAAAATAAGGGAAGTGCAC
ATTAAAACACAAGAAACCATCTCAGATCCAACTAATATTTAGCGTGCATACAAATCAAAAGCTGGAAAGGGTGTGGAAAAACAGGAATACATTGCTAGTGAGCATACAAATTGGCACAGCCTCTTTTA
AAGACAATTGTGTATCACCCATTAAATTTTAAAAGTCACATACCCTGTGACCTAACAATTCCAACTTTTAATGTCCTAAAGAAACATACATGTGTTCACAAGATAGCCTGTACAATGATGTCAATTGC
ACCTTTGCTTGTACAGTAGACCCCCTTATCTGCATTTTCACTTTTTGAGGTTTCAGTCATCCAAGGTCAACCACAATACAAAAATATTAAATGGAAAATTCCAGAAACGAACATAAGTTTTAAACTTC
AAACCTTTCTGCATAGTATAATAAAAATCTCTCACTATCCCTCTCCATCCTGCCTGGGACAGGAATCATCCCTTTGTCCAGTGTATCCACAATGTATACACTCATTATATACCCATTTTATAATGCCC
ATTAGTCATTTCTATTATCAGATCATAAAAAAACATAGTACATAGAGGGTTTGGTATTATTCATGGTTTCAGGCATTCAGTGAGGGTCTTGGAAAATATCCTCCATGATGGGGGAGCTACTGTAATAC
TATGAAATTGGAAAAACCAAAATACTCATCAAGAGGATGGACTATGGTACACATGATGAAGTATTAAGTATCAATGAAAAAGAGAGAGTCCTACATGTCCGGCATGGAAGGATCTCCAGGAGACAATG
TTAAAAGTTTGGGGGAAAAATTGAAAGACAATACCTGTAATACATATGATACTAGTGATGTTAAATCACATCACACACACACACACACACACACACACACACACACAAATACTGTATAGTGTACTTCT
ACAAGTACATATTTGTGTATTATATAGAGAGAAGGTCTGGAAGGATACTAACCAAACTGTCAACAGTAGTTTGGTAGCGTGCATTAGCTTTAACTGTAATGTTTGATGTTTTTGAATATGCATTTATG
TATTGTTTGTGTAATGACAAATTAATAAATTAGAAATAAAATAAAA

hide sequence

RefSeq Acc Id:

NR_130136

RefSeq Status:

VALIDATED

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	150,408,298 - 150,466,422 (+)	NCBI
CHM1_1	3	150,089,196 - 150,140,980 (+)	NCBI
T2T-CHM13v2.0	3	153,159,594 - 153,217,686 (+)	NCBI

Sequence:

show sequence

AGTCGGCAGCGGCGGCGGCAGCGGGGCTGCTGCTCCTCCCAGCATCCCTGGCGCGGCCATTTCA
GCCCCATCTTGGCCCAGCGGAGGGAGCTGCAGCCGCCGCTTCAGCAGTTTGAATTTCAGTTTCTTCGGGGTTTAGGAATTGGGCGCACCGAGGAGGAGCCGGAGAAGCCACCACCGCTACCTCACACA
GCCGGGGCGCCTCCGGTCCCGTGCCAGCGGTCTGCCGCCGCCGCCCCTCTCTGAGAGAAGCCGCGAGGGGAGGCCGAGACCGCCGTCGCCGCCCGCCCGCAGGGGTGGTTCCCCCTGTAAGGGGAGGA
CCGAGCCGGCTTTCCCCTCCCCCAGAGCGGGTTTCCGCCTGAGGCAGTCGACATGTCCCTGGGGCTGAGCTCCGGCTAGAGCCGGGGAGGGAGGGCCGCCTGCCCGCGCCACAGCCCCACCGCCCGCC
CGCGGACCTTCAGCCAGCTCCGGCCCGCGGCTCCCGGCTGAATTAGGCATCTCCGACTCCGGACTCGCCGCTCCTTCCCTCAGTCAGAGAGCCCAGCGCTGACGCCGGCACCGGCCTGAGGAGCCCGA
GCGGGGCAGCACCGCCCCTCACGCCGCCGCCACCGCCTCCTCCTCCTCCTCTTCGCCCTCCCACTCCCACCCCCAGCCAAGGCCTGCTGACCGCGCCGAGCGCCGAGCTGGACTGACCACGGCTGCCC
GGAGACGAGAGAGGAAGCAGCCGGCCCGCCCCTGGGTTCGCGCTCTCGCCGCCTCTGAGGGAATTGAATTGAGGCGCCGCGGCTGCGAGAGCTAAAAAGGAAGGAGGAGCCGCCGCGGGACTGAGACG
GGGGCAGAGCCGAAGAGACCGACACAGAGAAGGAAACGAGGAGGAGGATGTCTCACCGGGCGGCCAGCGCCTGGATCAGCCCGTGACTCTTAACAGCGGCGGGCCTCAGACCCCAGCGCAGACTCGGA
CTTTGTCTTTGGGGGCCCGTGCTCTGCCCTCCCCGGTTTCCGACAGGACCCAGAGGAGCCGGCGTGCCTCTCTGCCCTCCAGCCTTCTTCACCATGTCCAAGATGCCGGCCAAGAAGAAGAGCTGCTT
CCAGATCACCAGTGTCACCACGGCCCAGGTGGCCACTAGCATCACCGAGGACACCGAGAGCTTGGACGACCCGGACGAGTCACGCACAGAGGACGTCTCCTCCGAGATTTTCGACGTCTCTCGGGCCA
CGGATTATGGCCCTGAGGAGGTCTGCGAGCGCAGCTCTTCCGAAGAGACGCTTAACAATGTTGGGGATGCGGAGACTCCCGGGACCGTCTCCCCAAACCTCCTCCTAGATGGGCAGCTGGCAGCGGCG
GCTGCTGCTCCCGCCAACGGAGGAGGAGTCGTTTCGGCCCGGAGCGTGTCTGGGGCGCTCGCCAGTACCCTGGCGGCGGCTGCCACTTCGGCCCCCGCCCCCGGAGCACCCGGCGGCCCCCAGCTCGC
GGGCTCATCCGCCGGGCCAGTGACTGCAGCCCCATCTCAGCCTCCCACCACATGTAGTTCCCGTTTTCGCGTGATCAAGCTGGACCACGGGAGCGGAGAGCCCTATAGACGCGGCCGATGGACGTGTA
TGGAATACTATGAGAGGGATTCAGACAGCAGCGTCCTGACTAGATCCGGGGATTGCATTAGACACAGCAGTACTTTTGACCAGACTGCGGAGCGGGACAGCGGCCTGGGCGCCACCGGAGGGTCGGTG
GTGGTAGTAGTGGCCTCCATGCAGGGGGCGCACGGGCCCGAGTCGGGAACTGACAGCTCCTTGACTGCTGTGTCACAGCTACCCCCGTCGGAGAAAATGAGCCAGCCCACTCCGGCCCAGCCGCAGAG
TTTTAGCGTTGGGCAGCCACAGCCGCCGCCGCCACCCGTAGGTGGGGCTGTGGCTCAAAGCTCGGCTCCGCTGCCGCCGTTCCCGGGAGCCGCGACCGGGCCGCAGCCAATGATGGCAGCCGCGCAGC
CCAGCCAGCCCCAGGGAGCGGGGCCCGGGGGACAGACTCTGCCGCCGACGAATGTAACCCTGGCGCAGCCGGCTATGTCCCTGCCTCCGCAGCCGGGCCCTGCAGTGGGCGCCCCCGCGGCGCAGCAG
CCCCAGCAGTTCGCGTATCCTCAGCCTCAGATACCGCCCGGACATTTGCTGCCCGTCCAGCCCTCCGGCCAGAGTGAGTACCTGCAGCAGCACGTGGCCGGCCTGCAGCCGCCAAGCCCCGCGCAGCC
CTCGTCCACCGGCGCCGCAGCGAGCCCCGCCACGGCGGCCACCCTTCCCGTGGGCACCGGCCAGAATGCTTCCTCGGTGGGCGCGCAGCTCATGGGCGCGTCTTCCCAGCCCAGCGAAGCCATGGCCC
CCCGGACGGGACCAGCGCAAGGCGGGCAGGTCGCGCCTTGTCAGCCGACTGGAGTGCCCCCGGCTACTGTGGGAGGCGTGGTGCAGCCGTGCCTCGGTCCTGCCGGGGCTGGGCAGCCCCAGTCCGTG
CCTCCGCCGCAGATGGGTGGCAGTGGTCCGCTGTCAGCCGTACCTGGTGGCCCTCACGCCGTGGTGCCCGGAGTTCCAAACGTGCCTGCAGCCGTGCCCGCTCCAAGCGTGCCTAGTGTGTCTACCAC
TTCTGTTACTATGCCAAATGTACCCGCGCCTCTGGCCCAGTCGCAACAGCTGAGCAGCCATACGCCAGTCAGCAGGAGCAGCAGCATAATCCAGCATGTTGGGCTGCCCTTAGCGCCAGGCACACACA
GCGCACCAACAAGTCTACCACAGTCTGACCTAAGCCAGTTTCAAACTCAGACCCAGCCTTTAGTCGGGCAAGTCGACGATACTAGAAGAAAATCAGAACCCCTACCTCAACCACCACTTTCTCTCATT
GCTGAAAATAAGCCTGTTGTGAAGCCGCCTGTTGCAGATTCCCTGGCAAACCCCCTTCAGTTAACACCTATGAACAGTCTGGCCACCTCTGTATTCAGCATAGCTATTCCTGTTGATGGTGATGAAGA
CAGGAATCCTTCAACTGCTTTCTACCAAGCGTTCCATTTGAACACGTTAAAGGAATCAAAGAGCCTCTGGGATAGAATTTTTTTTAGAATTCAGCATCGGAGGAGGAATGTGACATAATAATGATCGA
AAGCCGAAAGTTTAAAAGTTGTGATGCCCTCACATGGTTGGAGGGTTATTCTAGCTTCTAAGGACTGAATGTTGTCCACAAGAGTGTCATCAGGTCATAAATTGTGCATCTGGGGGAGGTGTTGTAGC
CATTGACAACAAAATAGAACAAGCAATGGATCTGGTGAAAAGCCATTTGATGTATGCAGTAAGAGAAGAAGTGGAAGTTTTAAAGGAACAAATAAAAGAATTAGTTGAAAGAAACTCTTTACTTGAAC
GAGAAAATGCACTGTTAAAATCTCTTTCAAGCAATGATCAATTATCCCAACTCCCAACCCAACAGGCCAATCCTGGTAGCACTTCTCAACAGCAAGCAGTGATAGCACAGCCTCCGCAGCCAACGCAA
CCTCCACAGCAGCCGAATGTCTCCTCAGCATAAAGCTTTCTTAAGCCTCATTAAGAAAAAAACTGAAAGCAATCTATCCTTGTGTGCCACTGGTGTTCTTTCCACTTTATACGAAAGCAAGTAGCCAT
GCTTTGGTTGTGTGTTTGGCCTTTTCAGTATTAGACAATCATTCTACAAGAGCTTTTCCTCTCTCTGAGATGTCATGCAGCGCTGTTGATGTCCAGTTCTATGTCATCAGTACACAAGGAGAATAATA
GATGGGGTTTATTAAAGCGAGCAAAGTCTGCATTTTACCTGGTGCGCATGAGTGGGGTCTTTAAGAGTTTTGGTGGCTCTCCCATGTTTCCTATTACCCATGGATTTACCCTGAGCCTTCCTATCACA
TTATAAATAACAGTTCATCTAAAGAGCCACTTTTCTTTCTGATTCAGTAACATTTGCCTACATAAGTTTTCATTTATTTGTGTTTTATTTATTACAGGGCTGCTATTTTCATAATGTACATGAACAAT
GTCACAGAACTTTTTTAATTTTTTTGAATAATTATAAGTATCAGTAAAGGAAGTGAAAGACAGGATTGCATTTAATAGATAAAACGTTTAGGCAATAATTGAACAAAAGAATCCTGGCATATTTCTAA
CACTAATGGCAATTTACTTATGGTATTTATTTTCAGTAGTAAAGACCCAGCTTGAATGTAAATTTTGTATAGTGTAAGTATGAAGAACATAGTGCAACTGTACAGGTAGTCACCAGTTATTGTGATAT
GATAAATAATTGGGCTATTTTGATGAAGAAAACTTTGTTCATTTGTTTCTACTTTCTAAGAGAAATTGCCACGATTCCTCTGCTTTTCAACATTTCGTATGACTTTTTTTTCGGGTGGGAATAAAAAG
CTGTGAAATTGTTCAACCTACTTTGTAACCAAAGAAGCAAAGCTGTGTAATGGAGTTTGGTTTTTTTTTGTTGTTTTTTTTTTTTTGTCTTTTTTTTTTTTTATAATGCACATTCTTTATGTATTTTT
ATTTAGTGTTTTCTCAGTCACAATTTTCTTTACTGTCTAGCATGATCTGCATGACCTATAATCTTTGAACCACTTTCGTACCTCATGTTTTTATCCAGCACTCTTATTGTAATATGTACTAGTCTGTG
AACAATGTCAAATAAAAGAGAACGAACAGGTAGTTTGGTGGAGCTGAGCTAGTGTACAATACACTAGTTGTAAAAAAAAAAAAAAAAAAAAGTGAGCCATCTTTTGTTCATTTAAAATGGTGTTTTGA
ATTTCGTATGCAGAAAACGTTTTGTTACATTGCAGATTTTAATGTATTTAATAAATGCAACATGCAGATTAAGTGCAGTGTATACTGAGTATTTAAATTAAAATGTACATTTCATAAATACAGTTTCA
AAAGAAAGCATCATTTTGTGTATACTAACACATTAAGTGTATGTCAGAAATTGATGTATAAATATATATTTTAACATTTTCTGAAATTAAACTGCAGTTTTGTTGAAATATTTGGCTCTATATGTGTT
CAAAATTTGACTAGATTTGTATTTTCACAGTTCAAAATACTCCTTAAAGACCTGTTAATAATGACTTACTGATAGTTCTTAAATTTTCAAAGTAAAACAATTTAAAGAATGCAAAAATAGTGAGCAAT
ATTTGTACTCAATATTCATATTATGTTAGTGATACTTAAGTAGGAAATCCTTGTCTACCAAAACTTTTACTTGAATTCAGAAAGGTGCCTGTAGAAATTAACATGCACTGCATCTGTAGCCAGCTAGC
TAATCAGAGTTAATGAGAACCAGTAGTTAGTTCTCCGTGTTAAAAGACTTATTTGAAGTAAAAATTTAATCAGATTAGCCACAAACAAACAAGGCATAAAATTGGGATGTACATGAGATTGCCAAATA
TTTTCTATTCTAGTTGTGCTGCAAGACATTGAACAAAATGTTAATGAATAACATTATAAATCAAGGAACTAAGTACATAGGCTTGAGTAAGCAACCCTAAGGATGTGTAGTAAGATTCCAAGTAGAGC
TGCTACAGGTGAGATACTTAATGGAATGTGAAACTTCACTGTTGGACTGTTAACCGAAAAGGTTTGCTGGCTGTGCCCCTCCAGTGCTAACTGTGACATGTGATATTTAATACAGGTGGAGAAAAACT
AGTCTTAGAAATGGGATTTTTGTGAAAATAGATTCCATTTTGATTCTGGGGCTGGAAAAACACTTCATAAACAAAGTAATAGTCTCCAAGGAAATGAATAATAAGGTTTAAAATGGTAACAGCAGTTA
TTACTACTTTTATATTAAGAAAAACAGTAGAAAAGGAGAGAAAATATGGGTAGTTCACAGAAGAGATAAATGGCAGTTTCTAAAGGTTCAACCTCTAGTAACCTAAGAAATGCAAATTAATGTTTTTG
GCGAATTGTAATAAGTGTCCTAAGTAGCAGGACTTAACATAGAAAGAAAGACAGGCTTTCCTGTGTACTTTTAGAAAGTAATTTGGCAGTATGTATCTAGAGCCTTAAATAATAAGCTTTCCAGTGTA
ACGACAGGAGAAGATACTCAACTCATGGTCCATTGTTCAAAAATGCAGAATTATTGTGGTGTCTGCCCTCTGCTTTCCCATCATCCCCTCCCCTCAAAATCCAAACTATCCCTACTGTCAACCCTTCC
CCCAGCTGATTGTTTAGGATCTTAAGTAACTTCCAATTCAGCTTTGGAGATTTAGTCTCCTGCTCCAAATAGTTGTAAATATTAACTGATTGAGATCCCAATTTGGAGGCACAGTCTTACAGGAATGC
CATCTATCTAATTCTGTCAGTGTAATGCCCATAGAGCAAGGTCCCACATAAGCTTTTCTGTTTTAATTTAGCCGGTAAATCATAAGTAGAAATTTTTCTGATACGGTAATTGTCTACAATTCAAACCT
AACTTTCCCCAAATAAAATTTAGTTTGTTCCGATGTGATCTCACAGCTTGCCACACCAAAAACAAATAGTAGGGGTTAGGAGGCATTAAATAAACAGTTTCCTTAACTCCTGATTGTCCAAAATAGCT
GAATTTTTCCAATTCTATTTATAATATCCTATGCTAATTAGAAGTATTGAGATAACGTTTTATAATCAAGCCTCCAGTGACTGGGGATCACAGCTGCCATTATTCACAAGAATTTTCACAGGTGAATG
ATTATATTTCTCCAAGTTGCAAACTCCAGTAATTCATGGACCTTTTTTTAAAAAAAAAAAAAGTCTTAATAGAACCAGAATATCTCTGTTCTTGAAAATTTATCTTTGCAGAACCAGAAATAGCTAAT
TGTCTGGAAACAATTTTTAAGATTTGAAGTCACATTTTTAAAAGAAGCTTTATGGCTCAGTGGCAAGCACTTTGTGACATTTCTTTAATAATCCTATGAAAAGGACAAAACCCAGCCCTCAAAATTGA
CAATTTGAGGACATAATAAGCCAACTGATAATGCAGTGAGGAATACTTGTTACTATGTACAGTCAGGGATGGTTTTGTCAGGGTAGGTTTCCTCAAAAACATGACACCTGAGTCTTGAAGGTCATAAG
AGCCAGAGGGAAGGGTGTTCCAAGCACAAGAAAAGAGAACTCAATGGCTTAAAAGTATAAACAAGGCTCCTAGGGCAGCCACAGAATTGCATTGGAGACAGGCAGGCAGTGACTTCCCCACTGACCTA
GTATTTTGGCATCTATTCAGAAAGCAAGAATGATTTATTGAATGGTTTTAAGCAATGGGATACTATGCTCAAATTATGCTGGATGTGCACAATTCCAGTGGCAGATGGGAGGTAGGTTAGAGTAGCTG
AAACTGGAAGCTGAGAAATAATTTAGGAGGGATGACAATCCGGAAAATAAATGAAAGGGCAAAATTACATAGGCAATTTTGTGAAGGTCATGAAGGAAGTTTGTCTTGGGTCTTTCTGTACCATTTTC
CTCTCCACAATGAACATCCCATTCCCAGTGTCAGGTATCAGGTGCCTATTTTCTTTTTTTCTTTTTTCTTTTTTTTTTTTTTTGAGACAGAGTCTTGCTGTGCTCAGGCTGGAGTGCAGTGGCAAGAT
CTCGGCTCACTGCAACCTCCGCCTCCCAGGTTCAAGCGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGCGTGTGCCACCATGCCAGGCTAATTTTTGTATTTTTAGTAGAGACAGGGT
TTCACCATGTTGGCCAGGTTGGTCTTGAACTCCTGACCTCAAGTCATCTCCCCCGCCCGCCTGGGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACCGCACCCAGCTGCCTATTTTCTTGTCCC
TCCAAAAAAAGATTAAAGAGTCCCAACTCATACTTGAAAGTTTGACTCGGTCTTTTCCTTCCAACAGTTATAAATCTGTGAAATGAAAGTCTTTGTTTCCTTAAAGGGATTTCAAGAATTTAACAAAA
GGGTTGGGGAATGGAACCTTTGCTGTCACTATGCCTGTCTCTCAATTCTACCCTAAAGGTAAACTAAATGGAATCCTTTTATGGTGACTAGGATTAGGATGTTGATTCCAAAGCCTTTCCCTAAAATC
TATTCCTTGCTCCCTGGAAAGGATAATACAGGTTCTGGCCCCCACTGTAGGTACTGACAGCCCAAGGCAGAATAGGTTTTGCTAGGCTTTAGCCTTTTATTCTTTGACATAGGTCAGTCCTGCAGGCT
TCTTTTTTCTAAGTCTCCTGCCTATCCAAAACCAGACCTTTTCTCCCACCTCCTTCTGCTTCAAGCCTCTTAATAATCCATATTTCTATTTTCTAGCAATAGTAATAGTTTATTATTTAGTGATGTAT
ACTTGCACCCCATTTACTCCTTTTCAATATTTCAGGATACATCTTTGTCCTGTATTTCTGTACCAGTTCACAGAATTTCTACAGCAAGATCCCTTTAAATGTATGGCTTTCCTTCATAGGTTGCAAGG
ATTACTTTATACAAGTGCTACTGTAACTATATCTTTTGTGGAGTACAATTGGTATGACATGCTGTGTTCATAGATGAAAATGCTAAGTGAGGCACTCTGAAGCAAGTTAAAGTTCACAGACATTCTTG
CTTGCCCACCACCCCCCCGAACCCCGCCATGGAATCATCAAATAAGAAAAATAAGACAGATTTTCAGATTGGTGATGGCAAAGTAAGACGCTGGTATTTTGCACTGGCGCAGTCCATTTAGTTGTTGA
ATTTGTTCAGCATACCTGGATGGTGAGTGAGTTAGCTTTATTTTTCATTCTCAGCAGGGAAACTGATAGACTAGGCAGTTTGGGGAATTTTCCCATTGTCTACTGTCATGGGTCCATAGTATTTAAGT
TTACAGACTACAACATTGTCCACAGAAGCCATATTTATCCCCTTGGAGGGAAGGGAAAGGTGTGCTAACTTAGATCATAAAAACAACTGAATTTTAAAACAAGGCAAATGCCACAGTTCAACTTCTCC
ATAAAAAAGTTAAGTTCATCTCTCCATTCTTTTGCATGCCTACAATATTTCCATATAACAACTGTAAAATACTCTTGCCTGCTGCAATCCAAATGTTATCCGGATCACAGTTCTTGCTGTCATTTCAC
AGGCATGCAATGTATCTATAGATAGGTCATATCATACCTGAGGAAGATCAGAGACAGCAAGGGAACATTTTCCCCACACTTGAGATGGAAATAATAACAGGTCAGTGGCTAATAAAAAGAAACATGTA
TGACTTTGTAAAACCCTAAAAGTGATGTTTTCAAGAAATTTAGGTTTCTTTTTTTTATTTTATAAAAAAAATGTTGACATGCAATTTAATTCTATTTCAATTTAGGTGCTGCAACCTGTACTGGATGT
TTGGGGATAGAAAGATGAATGGGACATGATTTGTGTGCTCCAATGAGCTCAGTCCAGTGTAAGTGTAAAAGTTAAAGTGCCATATTGTTTATTCAGAGTATATGTTATAGTTTGTGAACCTTATATCA
TTTGTTAAATGAAAGGTTTTTATAAATCAACAGTAATATTGCCATCCCATGTAAAAATCCTTTGATATTGCCAGGAAACAACTTTAAATCACCAGAAAGCTTTAACATCAAATAATACTTTTAGAAGG
AGGGGAAAAGCCTTCCACCTCGACATCGAGCCTATGAAGTATTCCCTAAAAAAGAGGAACTAATCTGAGAAAAGTTTACACATTTTTAATACTCTAAGTTGTAGATAATGAAATTGATTTAAATCAAA
GTTAACTAGAATAGGATTCATGTGTCATGAATTATATTGTCTATTGTCTCATAAGCAACAAGTGACACTTATTATCTTGGCTGACAAAATCAGCTACCATTTAATGAACCAAGTTAAGAATAACTCAG
GTGACTGATACCAAAAATAAATCTCTAATACAGCTGAGAATCCAGAAACACAAATAATATGTTGAGTAAGTAATAAAAGTGACATTTCAAATTAGTAAGGAAAAAATGGATTATTCAACAAATAGTAT
GGGATAGCATAACAATTTAGAAGAAATATAAAGTTAGATCTTTCACAAAAATTAATTCTAGCTAGACTAGCAGTTAGTCTTCTACTTTTTGGTTACTCCCTTTTAGAAATTGGAAGCTATGAAGCTAT
ATACCCTGTCCATTTGAAAATGCACATAAGCAAAGAACTTTACAAATAGGTTATAAAGAGAAGCTCAATCTCAGCAAAATAAGGGAAGTGCACATTAAAACACAAGAAACCATCTCAGATCCAACTAA
TATTTAGCGTGCATACAAATCAAAAGCTGGAAAGGGTGTGGAAAAACAGGAATACATTGCTAGTGAGCATACAAATTGGCACAGCCTCTTTTAAAGACAATTGTGTATCACCCATTAAATTTTAAAAG
TCACATACCCTGTGACCTAACAATTCCAACTTTTAATGTCCTAAAGAAACATACATGTGTTCACAAGATAGCCTGTACAATGATGTCAATTGCACCTTTGCTTGTACAGTAGACCCCCTTATCTGCAT
TTTCACTTTTTGAGGTTTCAGTCATCCAAGGTCAACCACAATACAAAAATATTAAATGGAAAATTCCAGAAACGAACATAAGTTTTAAACTTCAAACCTTTCTGCATAGTATAATAAAAATCTCTCAC
TATCCCTCTCCATCCTGCCTGGGACAGGAATCATCCCTTTGTCCAGTGTATCCACAATGTATACACTCATTATATACCCATTTTATAATGCCCATTAGTCATTTCTATTATCAGATCATAAAAAAACA
TAGTACATAGAGGGTTTGGTATTATTCATGGTTTCAGGCATTCAGTGAGGGTCTTGGAAAATATCCTCCATGATGGGGGAGCTACTGTAATACTATGAAATTGGAAAAACCAAAATACTCATCAAGAG
GATGGACTATGGTACACATGATGAAGTATTAAGTATCAATGAAAAAGAGAGAGTCCTACATGTCCGGCATGGAAGGATCTCCAGGAGACAATGTTAAAAGTTTGGGGGAAAAATTGAAAGACAATACC
TGTAATACATATGATACTAGTGATGTTAAATCACATCACACACACACACACACACACACACACACACACACAAATACTGTATAGTGTACTTCTACAAGTACATATTTGTGTATTATATAGAGAGAAGG
TCTGGAAGGATACTAACCAAACTGTCAACAGTAGTTTGGTAGCGTGCATTAGCTTTAACTGTAATGTTTGATGTTTTTGAATATGCATTTATGTATTGTTTGTGTAATGACAAATTAATAAATTAGAA
ATAAAATAAAA

hide sequence

RefSeq Acc Id:

XM_011513337 ⟹ XP_011511639

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	150,408,298 - 150,423,451 (+)	NCBI

Sequence:

show sequence

CTTCCCTCAGTCAGAGAGCCCAGCGCTGACGCCGGCACCGGCCTGAGGAGCCCGAGCGGGGCAG
CACCGCCCCTCACGCCGCCGCCACCGCCTCCTCCTCCTCCTCTTCGCCCTCCCACTCCCACCCCCAGCCAAGGCCTGCTGACCGCGCCGAGCGCCGAGCTGGACTGACCACGGCTGCCCGGAGACGAG
AGAGGAAGCAGCCGGCCCGCCCCTGGGTTCGCGCTCTCGCCGCCTCTGAGGGAATTGAATTGAGGCGCCGCGGCTGCGAGAGCTAAAAAGGAAGGAGGAGCCGCCGCGGGACTGAGACGGGGGCAGAG
CCGAAGAGACCGACACAGAGAAGGAAACGAGGAGGAGGATGTCTCACCGGGCGGCCAGCGCCTGGATCAGCCCGTGACTCTTAACAGCGGCGGGCCTCAGACCCCAGCGCAGACTCGGACTTTGTCTT
TGGGGGCCCGTGCTCTGCCCTCCCCGGTTTCCGACAGGACCCAGAGGAGCCGGCGTGCCTCTCTGCCCTCCAGCCTTCTTCACCATGTCCAAGATGCCGGCCAAGAAGAAGAGCTGCTTCCAGATCAC
CAGTGTCACCACGGCCCAGGTGGCCACTAGCATCACCGAGGACACCGAGAGCTTGGACGACCCGGACGAGTCACGCACAGAGGACGTCTCCTCCGAGATTTTCGACGTCTCTCGGGCCACGGATTATG
GCCCTGAGGAGGTCTGCGAGCGCAGCTCTTCCGAAGAGACGCTTAACAATGTTGGGGATGCGGAGACTCCCGGGACCGTCTCCCCAAACCTCCTCCTAGATGGGCAGCTGGCAGCGGCGGCTGCTGCT
CCCGCCAACGGAGGAGGAGTCGTTTCGGCCCGGAGCGTGTCTGGGGCGCTCGCCAGTACCCTGGCGGCGGCTGCCACTTCGGCCCCCGCCCCCGGAGCACCCGGCGGCCCCCAGCTCGCGGGCTCATC
CGCCGGGCCAGTGACTGCAGCCCCATCTCAGCCTCCCACCACATGTAGTTCCCGTTTTCGCGTGATCAAGCTGGACCACGGGAGCGGAGAGCCCTATAGACGCGGCCGATGGACGTGTATGGAATACT
ATGAGAGGGATTCAGACAGCAGCGTCCTGACTAGATCCGGGGATTGCATTAGACACAGCAGTACTTTTGACCAGACTGCGGAGCGGGACAGCGGCCTGGGCGCCACCGGAGGGTCGGTGGTGGTAGTA
GTGGCCTCCATGCAGGGGGCGCACGGGCCCGAGTCGGGAACTGACAGCTCCTTGACTGCTGTGTCACAGCTACCCCCGTCGGAGAAAATGAGCCAGCCCACTCCGGCCCAGCCGCAGAGTTTTAGCGT
TGGGCAGCCACAGCCGCCGCCGCCACCCGTAGGTGGGGCTGTGGCTCAAAGCTCGGCTCCGCTGCCGCCGTTCCCGGGAGCCGCGACCGGGCCGCAGCCAATGATGGCAGCCGCGCAGCCCAGCCAGC
CCCAGGGAGCGGGGCCCGGGGGACAGACTCTGCCGCCGACGAATGTAACCCTGGCGCAGCCGGCTATGTCCCTGCCTCCGCAGCCGGGCCCTGCAGTGGGCGCCCCCGCGGCGCAGCAGCCCCAGCAG
TTCGCGTATCCTCAGCCTCAGATACCGCCCGGACATTTGCTGCCCGTCCAGCCCTCCGGCCAGAGTGAGTACCTGCAGCAGCACGTGGCCGGCCTGCAGCCGCCAAGCCCCGCGCAGCCCTCGTCCAC
CGGCGCCGCAGCGAGCCCCGCCACGGCGGCCACCCTTCCCGTGGGCACCGGCCAGAATGCTTCCTCGGTGGGCGCGCAGCTCATGGGCGCGTCTTCCCAGCCCAGCGAAGCCATGGCCCCCCGGACGG
GACCAGCGCAAGGCGGGCAGGTCGCGCCTTGTCAGCCGACTGGAGTGCCCCCGGCTACTGTGGGAGGCGTGGTGCAGCCGTGCCTCGGTCCTGCCGGGGCTGGGCAGCCCCAGTCCGTGCCTCCGCCG
CAGATGGGTGGCAGTGGTCCGCTGTCAGCCGTACCTGGTGGCCCTCACGCCGTGGTGCCCGGAGTTCCAAACGTGCCTGCAGCCGTGCCCGCTCCAAGCGTGCCTAGTGTGTCTACCACTTCTGTTAC
TATGCCAAATGTACCCGCGCCTCTGGCCCAGTCGCAACAGCTGAGCAGCCATACGCCAGTCAGCAGGAGCAGCAGCATAATCCAGCATGTTGGGCTGCCCTTAGCGCCAGGCACACACAGCGCACCAA
CAAGTCTACCACAGTCTGACCTAAGCCAGTTTCAAACTCAGACCCAGCCTTTAGTCGGGCAAGTCGACGATACTAGAAGAAAATCAGAACCCCTACCTCAACCACCACTTTCTCTCATTGCTGAAAAT
AAGCCTGTTGTGAAGCCGCCTGTTGCAGATTCCCTGGCAAACCCCCTTCAGTTAACACCTATGAACAGTCTGGCCACCTCTGTATTCAGCATAGCTATTCCTGTTGATGGTGATGAAGACAGGAATCC
TTCAACTGCTTTCTACCAAGCGTTCCATTTGAACACGTTAAAGGAATCAAAGAGCCTCTGGGATAGGGGGGAAATCACATGGTATCTAGCATGGGACAAAGCAGCAAAATAAACCAAAAGGACAATCT
CTATTTTATATAGAAAATAAACATACTTTTCTGCATCCTGTGTACTTTAAGTATATCTATATTTTTGAAGGGTTCATACTGTGTTGAATTTTTCTTATGAAATAGTCACTTCCCCAGTGTATTTTAAT
GCAAATGCATATTCTATAAAATAAACTATATTTTAATTTT

hide sequence

RefSeq Acc Id:

XM_054348584 ⟹ XP_054204559

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	3	153,159,594 - 153,180,952 (+)	NCBI

RefSeq Acc Id:

XR_007095779

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	150,408,298 - 150,457,132 (+)	NCBI

RefSeq Acc Id:

XR_007095780

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	150,408,298 - 150,457,132 (+)	NCBI

RefSeq Acc Id:

XR_008486869

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	3	153,159,594 - 153,208,405 (+)	NCBI

RefSeq Acc Id:

XR_008486870

Type:

NON-CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	3	153,159,594 - 153,208,405 (+)	NCBI


Protein RefSeqs	NP_001290193	(Get FASTA)	NCBI Sequence Viewer
	NP_055594	(Get FASTA)	NCBI Sequence Viewer
	XP_011511639	(Get FASTA)	NCBI Sequence Viewer
	XP_054204559	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAG41223	(Get FASTA)	NCBI Sequence Viewer
	AAG41224	(Get FASTA)	NCBI Sequence Viewer
	AAG41225	(Get FASTA)	NCBI Sequence Viewer
	AAH44643	(Get FASTA)	NCBI Sequence Viewer
	BAA31644	(Get FASTA)	NCBI Sequence Viewer
	BAG59824	(Get FASTA)	NCBI Sequence Viewer
	BAG60098	(Get FASTA)	NCBI Sequence Viewer
	EAW78837	(Get FASTA)	NCBI Sequence Viewer
	EAW78838	(Get FASTA)	NCBI Sequence Viewer
	EAW78839	(Get FASTA)	NCBI Sequence Viewer
	EAW78840	(Get FASTA)	NCBI Sequence Viewer
	EAW78841	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000354543
	ENSP00000354543.2
	ENSP00000510392
	ENSP00000510392.1
GenBank Protein	O75157	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_055594 ⟸ NM_014779
- Peptide Label:	isoform 1
- UniProtKB:	Q9H2Z7 (UniProtKB/Swiss-Prot), Q9H2Z6 (UniProtKB/Swiss-Prot), Q6PI50 (UniProtKB/Swiss-Prot), D3DNI5 (UniProtKB/Swiss-Prot), Q9H2Z8 (UniProtKB/Swiss-Prot), O75157 (UniProtKB/Swiss-Prot)
- Sequence:	show sequence MSKMPAKKKSCFQITSVTTAQVATSITEDTESLDDPDESRTEDVSSEIFDVSRATDYGPEEVCERSSSEETLNNVGDAETPGTVSPNLLLDGQLAAAAAAPANGGGVVSARSVSGALASTLAAAATSA PAPGAPGGPQLAGSSAGPVTAAPSQPPTTCSSRFRVIKLDHGSGEPYRRGRWTCMEYYERDSDSSVLTRSGDCIRHSSTFDQTAERDSGLGATGGSVVVVVASMQGAHGPESGTDSSLTAVSQLPPSE KMSQPTPAQPQSFSVGQPQPPPPPVGGAVAQSSAPLPPFPGAATGPQPMMAAAQPSQPQGAGPGGQTLPPTNVTLAQPAMSLPPQPGPAVGAPAAQQPQQFAYPQPQIPPGHLLPVQPSGQSEYLQQH VAGLQPPSPAQPSSTGAAASPATAATLPVGTGQNASSVGAQLMGASSQPSEAMAPRTGPAQGGQVAPCQPTGVPPATVGGVVQPCLGPAGAGQPQSVPPPQMGGSGPLSAVPGGPHAVVPGVPNVPAA VPAPSVPSVSTTSVTMPNVPAPLAQSQQLSSHTPVSRSSSIIQHVGLPLAPGTHSAPTSLPQSDLSQFQTQTQPLVGQVDDTRRKSEPLPQPPLSLIAENKPVVKPPVADSLANPLQLTPMNSLATSV FSIAIPVDGDEDRNPSTAFYQAFHLNTLKESKSLWDSASGGGVVAIDNKIEQAMDLVKSHLMYAVREEVEVLKEQIKELVERNSLLERENALLKSLSSNDQLSQLPTQQANPGSTSQQQAVIAQPPQP TQPPQQPNVSSA hide sequence

RefSeq Acc Id:	NP_001290193 ⟸ NM_001303264
- Peptide Label:	isoform 2
- UniProtKB:	O75157 (UniProtKB/Swiss-Prot), B4DN36 (UniProtKB/TrEMBL)
- Sequence:	show sequence MSKMPAKKKSCFQITSVTTAQVATSITEDTESLDDPDESRTEDVSSEIFDVSRATDYGPEEVCE RSSSEETLNNVGDAETPGTVSPNLLLDGQLAAAAAAPANGGGVVSARSVSGALASTLAAAATSAPAPGAPGGPQLAGSSAGPVTAAPSQPPTTCSSRFRVIKLDHGSGEPYRRGRWTCMEYYERDSDS SVLTRSGDCIRHSSTFDQTAERDSGLGATGGSVVVVVASMQGAHGPESGTDSSLTAVSQLPPSEKMSQPTPAQPQSFSVGQPQPPPPPVGGAVAQSSAPLPPFPGAATGPQPMMAAAQPSQPQGAGPG GQTLPPTNVTLAQPAMSLPPQPGPAVGAPAAQQPQQFAYPQPQIPPGHLLPVQPSGQSEYLQQHVAGLQPPSPAQPSSTGAAASPATAATLPVGTGQNASSVGAQLMGASSQPSEAMAPRTGPAQGGQ VAPCQPTGVPPATVGGVVQPCLGPAGAGQPQSVPPPQMGGSGPLSAVPGGPHAVVPGVPNVPAAVPAPSVPSVSTTSVTMPNVPAPLAQSQQLSSHTPVSRSSSIIQHVGLPLAPGTHSAPTSLPQSD LSQFQTQTQPLVGQVDDTRRKSEPLPQPPLSLIAENKPVVKPPVADSLANPLQLTPMNSLATSVFSIAIPVDGDEDSASGGGVVAIDNKIEQAMDLVKSHLMYAVREEVEVLKEQIKELVERNSLLER ENALLKSLSSNDQLSQLPTQQANPGSTSQQQAVIAQPPQPTQPPQQPNVSSA hide sequence

RefSeq Acc Id:

XP_011511639 ⟸ XM_011513337

- Peptide Label:

isoform X1

- Sequence:

show sequence

MSKMPAKKKSCFQITSVTTAQVATSITEDTESLDDPDESRTEDVSSEIFDVSRATDYGPEEVCE
RSSSEETLNNVGDAETPGTVSPNLLLDGQLAAAAAAPANGGGVVSARSVSGALASTLAAAATSAPAPGAPGGPQLAGSSAGPVTAAPSQPPTTCSSRFRVIKLDHGSGEPYRRGRWTCMEYYERDSDS
SVLTRSGDCIRHSSTFDQTAERDSGLGATGGSVVVVVASMQGAHGPESGTDSSLTAVSQLPPSEKMSQPTPAQPQSFSVGQPQPPPPPVGGAVAQSSAPLPPFPGAATGPQPMMAAAQPSQPQGAGPG
GQTLPPTNVTLAQPAMSLPPQPGPAVGAPAAQQPQQFAYPQPQIPPGHLLPVQPSGQSEYLQQHVAGLQPPSPAQPSSTGAAASPATAATLPVGTGQNASSVGAQLMGASSQPSEAMAPRTGPAQGGQ
VAPCQPTGVPPATVGGVVQPCLGPAGAGQPQSVPPPQMGGSGPLSAVPGGPHAVVPGVPNVPAAVPAPSVPSVSTTSVTMPNVPAPLAQSQQLSSHTPVSRSSSIIQHVGLPLAPGTHSAPTSLPQSD
LSQFQTQTQPLVGQVDDTRRKSEPLPQPPLSLIAENKPVVKPPVADSLANPLQLTPMNSLATSVFSIAIPVDGDEDRNPSTAFYQAFHLNTLKESKSLWDRGEITWYLAWDKAAK

hide sequence

Ensembl Acc Id:

ENSP00000417747 ⟸ ENST00000466814

Ensembl Acc Id:

ENSP00000354543 ⟸ ENST00000361875

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-O75157-F1-model_v2	AlphaFold	O75157	1-780	view protein structure

RGD ID:

6865980

Promoter ID:

EPDNEW_H6155

Type:

initiation region

Name:

TSC22D2_1

Description:

TSC22 domain family member 2

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H6156 EPDNEW_H6157

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	150,408,298 - 150,408,358	EPDNEW

RGD ID:

6865982

Promoter ID:

EPDNEW_H6156

Type:

initiation region

Name:

TSC22D2_2

Description:

TSC22 domain family member 2

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H6155 EPDNEW_H6157

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	150,408,641 - 150,408,701	EPDNEW

RGD ID:

6865984

Promoter ID:

EPDNEW_H6157

Type:

initiation region

Name:

TSC22D2_3

Description:

TSC22 domain family member 2

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H6155 EPDNEW_H6156

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	150,411,045 - 150,411,105	EPDNEW

RGD ID:

6801213

Promoter ID:

HG_KWN:46464

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4

Transcripts:

ENST00000361875, UC003EXW.1, UC003EXX.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	3	151,608,216 - 151,611,512 (+)	MPROMDB

Database	Acc Id	Source(s)
COSMIC	TSC22D2	COSMIC
Ensembl Genes	ENSG00000196428	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000361875	ENTREZGENE
	ENST00000361875.8	UniProtKB/Swiss-Prot
	ENST00000688009	ENTREZGENE
	ENST00000688009.1	UniProtKB/Swiss-Prot
Gene3D-CATH	Single helix bin	UniProtKB/Swiss-Prot
GTEx	ENSG00000196428	GTEx
HGNC ID	HGNC:29095	ENTREZGENE
Human Proteome Map	TSC22D2	Human Proteome Map
InterPro	TSC-22_Dip_Bun	UniProtKB/Swiss-Prot
	TSC22/BUN_CS	UniProtKB/Swiss-Prot
	TSC22_domain_protein_2	UniProtKB/Swiss-Prot
KEGG Report	hsa:9819	UniProtKB/Swiss-Prot
NCBI Gene	9819	ENTREZGENE
OMIM	617724	OMIM
PANTHER	TSC22 DOMAIN FAMILY PROTEIN 2	UniProtKB/Swiss-Prot
	TSC22 DOMAIN FAMILY PROTEIN 2	UniProtKB/Swiss-Prot
Pfam	TSC22	UniProtKB/Swiss-Prot
PharmGKB	PA142670697	PharmGKB
PROSITE	TSC22	UniProtKB/Swiss-Prot
Superfamily-SCOP	Delta-sleep-inducing peptide immunoreactive peptide	UniProtKB/Swiss-Prot
UniProt	B4DN36	ENTREZGENE, UniProtKB/TrEMBL
	D3DNI5	ENTREZGENE
	H0Y865_HUMAN	UniProtKB/TrEMBL
	H0Y8E9_HUMAN	UniProtKB/TrEMBL
	H7C4U3_HUMAN	UniProtKB/TrEMBL
	O75157	ENTREZGENE
	Q6PI50	ENTREZGENE
	Q9H2Z6	ENTREZGENE
	Q9H2Z7	ENTREZGENE
	Q9H2Z8	ENTREZGENE
	T22D2_HUMAN	UniProtKB/Swiss-Prot
UniProt Secondary	D3DNI5	UniProtKB/Swiss-Prot
	Q6PI50	UniProtKB/Swiss-Prot
	Q9H2Z6	UniProtKB/Swiss-Prot
	Q9H2Z7	UniProtKB/Swiss-Prot
	Q9H2Z8	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2015-11-24	TSC22D2	TSC22 domain family member 2		TSC22 domain family, member 2	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar